| 1 | Rasopathy | Enrichment | BRAF, HRAS, KRAS, MAP2K1, MAP2K2, MRAS, NRAS, RAF1, RRAS2, SOS1, SOS2 | 16.00 |
| 2 | Noonan syndrome 1 | Enrichment | BRAF, HRAS, KRAS, MAP2K1, MAP2K2, MRAS, NRAS, RAF1, RRAS, RRAS2, SOS1, SOS2 | 10.66 |
| 3 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | ACTA2, COL1A1, COL3A1, COL5A1, COL5A2, EFEMP2, ELN, FBN1, FBN2, TGFB2, TGFB3, TGFBR1 | 9.34 |
| 4 | Stickler syndrome | Enrichment | BMP4, COL11A1, COL2A1, COL9A1, COL9A2, COL9A3, VCAN | 9.22 |
| 5 | Noonan syndrome and noonan-related syndrome | Enrichment | BRAF, HRAS, KRAS, MAP2K1, MAP2K2, NRAS, RAF1, SOS1 | 9.13 |
| 6 | Connective tissue disease | Enrichment | ACTA2, COL11A1, COL12A1, COL2A1, COL5A1, COL9A1, COL9A3, EFEMP1, FBN1, FGFR3 | 8.52 |
| 7 | Junctional epidermolysis bullosa | Enrichment | COL17A1, ITGA6, ITGB4, LAMA3, LAMB3, LAMC2 | 7.76 |
| 8 | Marfan syndrome | Enrichment | COL2A1, FBN1, FBN2, LTBP2, TGFB2, TGFBR1 | 7.37 |
| 9 | Epidermolysis bullosa, junctional 1a, intermediate | Enrichment | COL17A1, ITGB4, LAMA3, LAMB3, LAMC2 | 7.27 |
| 10 | Junctional epidermolysis bullosa non-herlitz type | Enrichment | COL17A1, ITGB4, LAMA3, LAMB3, LAMC2 | 7.27 |
| 11 | Classic ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2, COL5A1, COL5A2, TGFBR1 | 7.27 |
| 12 | Lung non-small cell carcinoma | Enrichment | BRAF, EGFR, HRAS, KRAS, MAP2K1, NRAS | 7.04 |
| 13 | Nevus, epidermal | Enrichment | COL7A1, FGFR3, HRAS, KRAS, NRAS | 6.74 |
| 14 | Pilomyxoid astrocytoma | Enrichment | BRAF, FGFR1, KRAS, NTRK2, RAF1 | 6.74 |
| 15 | Ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, FBN2, TGFB2 | 6.68 |
| 16 | Cardiofaciocutaneous syndrome 1 | Enrichment | BRAF, KRAS, MAP2K1, MAP2K2 | 6.43 |
| 17 | Cardiofaciocutaneous syndrome | Enrichment | BRAF, KRAS, MAP2K1, MAP2K2 | 6.43 |
| 18 | Bethlem muscular dystrophy | Enrichment | COL12A1, COL6A1, COL6A2, COL6A3 | 6.43 |
| 19 | Lung cancer susceptibility 3 | Enrichment | ACTA2, BRAF, EGFR, FGF10, KRAS, TP53 | 6.25 |
| 20 | Ullrich congenital muscular dystrophy 1a | Enrichment | COL12A1, COL6A1, COL6A2, COL6A3 | 5.74 |
| 21 | Ehlers-danlos syndrome, classic type, 1 | Enrichment | COL1A1, COL1A2, COL5A1, COL5A2 | 5.27 |
| 22 | Renal hypodysplasia/aplasia 3 | Enrichment | BMP4, FGFR3, FRAS1, FREM1, FREM2 | 5.21 |
| 23 | Lip and oral cavity carcinoma | Enrichment | BRAF, EGFR, HRAS, KIT, TP53 | 5.21 |
| 24 | Thyroid cancer, nonmedullary, 2 | Enrichment | BRAF, HRAS, NRAS, PTEN | 4.91 |
| 25 | Noonan syndrome 3 | Enrichment | HRAS, KRAS, RAF1, SOS1 | 4.91 |
| 26 | Follicular thyroid carcinoma | Enrichment | BRAF, HRAS, NRAS, PTEN | 4.91 |
| 27 | Lacrimoauriculodentodigital syndrome 1 | Enrichment | FGF10, FGFR2, FGFR3 | 4.82 |
| 28 | Langerhans cell histiocytosis | Enrichment | BRAF, MAP2K1, NRAS | 4.82 |
| 29 | Multiple epiphyseal dysplasia due to collagen 9 anomaly | Enrichment | COL9A1, COL9A2, COL9A3 | 4.82 |
| 30 | Collagen vi-related dystrophies | Enrichment | COL6A1, COL6A2, COL6A3 | 4.82 |
| 31 | High bone mass osteogenesis imperfecta | Enrichment | BMP1, COL1A1, COL1A2 | 4.82 |
| 32 | Intermediate collagen vi-related muscular dystrophy | Enrichment | COL6A1, COL6A2, COL6A3 | 4.82 |
| 33 | Digenic alport syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 4.82 |
| 34 | Melanocytic nevus syndrome, congenital | Enrichment | BRAF, HRAS, NRAS, RAF1 | 4.62 |
| 35 | Mccune-albright syndrome | Enrichment | COL2A1, FBN1, GNAS | 4.46 |
| 36 | T-b+ severe combined immunodeficiency due to cd3delta/cd3epsilon/cd3zeta | Enrichment | CD247, CD3D, CD3E | 4.46 |
| 37 | Loeys-dietz syndrome | Enrichment | FBN1, TGFB2, TGFB3, TGFBR1 | 4.37 |
| 38 | Schimmelpenning-feuerstein-mims syndrome | Enrichment | HRAS, KRAS, NRAS | 4.23 |
| 39 | Autosomal recessive stickler syndrome | Enrichment | COL9A1, COL9A2, COL9A3 | 4.23 |
| 40 | Glioma | Enrichment | FGFR2, NTRK3, PTEN | 4.23 |
| 41 | Bladder cancer | Enrichment | EGFR, FGFR3, HRAS, KRAS, PTEN, TP53 | 4.19 |
| 42 | Differentiated thyroid carcinoma | Enrichment | BRAF, HRAS, KRAS, NRAS, NTRK1, NTRK3 | 4.19 |
| 43 | Nephrotic syndrome | Enrichment | COL4A3, COL4A4, COL4A5, FN1, ITGA3, LAMA5, LAMB2, PLCE1 | 4.18 |
| 44 | Arteriovenous malformations of the brain | Enrichment | BRAF, EGFR, IL6, KRAS, TIMP3 | 4.10 |
| 45 | Alport syndrome 3a, autosomal dominant | Enrichment | COL4A3, COL4A4, COL4A5 | 3.84 |
| 46 | Autosomal dominant alport syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 3.84 |
| 47 | Epidermolysis bullosa | Enrichment | COL7A1, ITGA6, LAMB3 | 3.84 |
| 48 | Hemimegalencephaly | Enrichment | AKT3, MTOR, PTEN | 3.84 |
| 49 | Alport syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 3.84 |
| 50 | Primary hypereosinophilic syndrome | Enrichment | FGFR1, PDGFRA, PDGFRB | 3.84 |
| 51 | Familial cerebral saccular aneurysm | Enrichment | ANGPTL6, COL3A1, TGFBR3 | 3.84 |
| 52 | Cutis laxa | Enrichment | COL5A1, EFEMP1, EFEMP2, LTBP4 | 3.81 |
| 53 | Skin disease | Enrichment | COL17A1, COL7A1, ITGB4, LAMB3, LAMC2 | 3.77 |
| 54 | Ovarian cancer | Enrichment | AKT1, EGFR, KIT, KRAS, MET, NTRK1, PDGFRA, PTEN, RRAS2, TP53 | 3.70 |
| 55 | Epidermolysis bullosa, junctional 1b, severe | Enrichment | LAMA3, LAMB3, LAMC2 | 3.55 |
| 56 | Testicular germ cell tumor | Enrichment | FGFR3, KIT, KITLG | 3.55 |
| 57 | Inguinal hernia | Enrichment | COL5A1, EFEMP1, FBN1 | 3.55 |
| 58 | Keratoconus | Enrichment | COL1A1, COL4A1, COL5A2 | 3.55 |
| 59 | Fetomaternal alloimmune thrombocytopenia 1 | Enrichment | ITGA2, ITGA2B, ITGB3 | 3.55 |
| 60 | Breast adenocarcinoma | Enrichment | AKT1, KRAS, TP53 | 3.55 |
| 61 | Lung squamous cell carcinoma | Enrichment | EGFR, FGFR3, KRAS | 3.55 |
| 62 | Colorectal cancer | Enrichment | AKT1, BRAF, FGFR2, FGFR3, IGF2, MET, NRAS, PIK3R1, TP53 | 3.53 |
| 63 | Myopia | Enrichment | COL11A1, COL2A1, COL4A4, FBN1 | 3.39 |
| 64 | Kidney disease | Enrichment | COL4A3, COL4A4, COL4A5, LAMB2 | 3.39 |
| 65 | Bethlem myopathy 1a | Enrichment | COL6A1, COL6A2, COL6A3 | 3.31 |
| 66 | Squamous cell carcinoma, head and neck | Enrichment | EGFR, PTEN, TP53 | 3.31 |
| 67 | Intervertebral disc disease | Enrichment | COL11A1, COL9A2, COL9A3 | 3.31 |
| 68 | Gallbladder cancer | Enrichment | BRAF, KRAS, TP53 | 3.31 |
| 69 | Gliosarcoma | Enrichment | EGFR, FGFR1, FGFR3, TP53 | 3.27 |
| 70 | Microform holoprosencephaly | Enrichment | CRIPTO, FGF8, FGFR1, GAS1 | 3.27 |
| 71 | Lobar holoprosencephaly | Enrichment | CRIPTO, FGF8, FGFR1, GAS1 | 3.27 |
| 72 | Acromicric dysplasia | Enrichment | FBN1, LTBP3 | 3.21 |
| 73 | Amelogenesis imperfecta, type ia | Enrichment | COL17A1, LAMB3 | 3.21 |
| 74 | Spondyloepimetaphyseal dysplasia, strudwick type | Enrichment | COL2A1, FN1 | 3.21 |
| 75 | Spondylometaphyseal dysplasia, corner fracture type | Enrichment | COL2A1, FN1 | 3.21 |
| 76 | Otospondylomegaepiphyseal dysplasia, autosomal recessive | Enrichment | COL11A2, COL2A1 | 3.21 |
| 77 | Dermatofibrosarcoma protuberans | Enrichment | COL1A1, PDGFB | 3.21 |
| 78 | Cervical cancer | Enrichment | FGFR3, TP53 | 3.21 |
| 79 | Pulmonic stenosis | Enrichment | BRAF, SOS1 | 3.21 |
| 80 | Pfeiffer syndrome | Enrichment | FGFR1, FGFR2 | 3.21 |
| 81 | Jackson-weiss syndrome | Enrichment | FGFR1, FGFR2 | 3.21 |
| 82 | Encephalocraniocutaneous lipomatosis | Enrichment | FGFR1, KRAS | 3.21 |
| 83 | Ras-associated autoimmune leukoproliferative disorder | Enrichment | KRAS, NRAS | 3.21 |
| 84 | Otospondylomegaepiphyseal dysplasia, autosomal dominant | Enrichment | COL11A2, COL2A1 | 3.21 |
| 85 | Ehlers-danlos syndrome, arthrochalasia type, 2 | Enrichment | COL1A1, COL1A2 | 3.21 |
| 86 | Fibrochondrogenesis | Enrichment | COL11A1, COL11A2 | 3.21 |
| 87 | Aortic dissection | Enrichment | COL3A1, FBN1 | 3.21 |
| 88 | Stickler syndrome, type ii | Enrichment | COL11A1, COL1A1 | 3.21 |
| 89 | Loeys-dietz syndrome 4 | Enrichment | TGFB2, TGFB3 | 3.21 |
| 90 | Cervix carcinoma | Enrichment | FGFR3, TP53 | 3.21 |
| 91 | Baraitser-winter cerebrofrontofacial syndrome | Enrichment | ACTB, ACTG1 | 3.21 |
| 92 | Interfrontal craniofaciosynostosis | Enrichment | FGFR1, FREM1 | 3.21 |
| 93 | Ehlers-danlos/osteogenesis imperfecta syndrome | Enrichment | COL1A1, COL1A2 | 3.21 |
| 94 | Localized junctional epidermolysis bullosa, non-herlitz type | Enrichment | COL17A1, ITGB4 | 3.21 |
| 95 | X-linked diffuse leiomyomatosis-alport syndrome | Enrichment | COL4A5, COL4A6 | 3.21 |
| 96 | Severe combined immunodeficiency | Enrichment | CD247, CD3D, CD3E, CD3G, LCK, ZAP70 | 3.20 |
| 97 | Giant cell glioblastoma | Enrichment | EGFR, FGFR1, FGFR3, TP53 | 3.17 |
| 98 | Semilobar holoprosencephaly | Enrichment | CRIPTO, FGF8, FGFR1, GAS1 | 3.07 |
| 99 | Normosmic congenital hypogonadotropic hypogonadism | Enrichment | FGF17, FGF8, FGFR1, GNRH1 | 3.07 |
| 100 | Multiple sclerosis | Enrichment | ITGB4, ITPR1, LAMA5, LAMB1 | 3.06 |
| 101 | Lung cancer | Enrichment | ACTA2, BRAF, EGFR, KRAS, MET | 2.98 |
| 102 | Angioma, tufted | Enrichment | GNA14, KDR | 2.97 |
| 103 | Cakut | Enrichment | ACTG1, COL4A1, FRAS1, FREM2, GDF6 | 2.86 |
| 104 | Amelogenesis imperfecta, type ie | Enrichment | COL17A1, ITGB6, LAMB3 | 2.80 |
| 105 | Melanoma | Enrichment | BRAF, FBN1, PTEN | 2.80 |
| 106 | Primary bone dysplasia | Enrichment | COL1A1, COL1A2, FGFR3 | 2.80 |
| 107 | Orthostatic intolerance | Enrichment | COL5A1, FBN1, RPS6KA3 | 2.76 |
| 108 | Catecholaminergic polymorphic ventricular tachycardia | Enrichment | CALM1, CALM2, CALM3 | 2.76 |
| 109 | Crouzon syndrome | Enrichment | FGFR2, FGFR3 | 2.74 |
| 110 | Contractural arachnodactyly, congenital | Enrichment | FBN1, FBN2 | 2.74 |
| 111 | Achondroplasia | Enrichment | FBN1, FGFR3 | 2.74 |
| 112 | Hematuria, benign familial, 1 | Enrichment | COL4A3, COL4A4 | 2.74 |
| 113 | Bleeding disorder, platelet-type, 16 | Enrichment | ITGA2B, ITGB3 | 2.74 |
| 114 | Telecanthus | Enrichment | COL11A1, COL5A2 | 2.74 |
| 115 | Ehlers-danlos syndrome, classic type, 2 | Enrichment | COL5A1, COL5A2 | 2.74 |
| 116 | Weill-marchesani syndrome 1 | Enrichment | FBN1, LTBP2 | 2.74 |
| 117 | Large congenital melanocytic nevus | Enrichment | HRAS, NRAS | 2.74 |
| 118 | Autosomal recessive cutis laxa type i | Enrichment | EFEMP2, LTBP1 | 2.74 |
| 119 | Testicular germ cell cancer | Enrichment | FGFR3, KIT | 2.74 |
| 120 | Spermatocytoma | Enrichment | FGFR3, HRAS | 2.74 |
| 121 | Geleophysic dysplasia | Enrichment | FBN1, LTBP3 | 2.74 |
| 122 | Alobar holoprosencephaly | Enrichment | CRIPTO, FGF8, GAS1, PLCH1 | 2.71 |
| 123 | Osteochondrodysplasia | Enrichment | COL1A1, COL1A2, FGFR3 | 2.67 |
| 124 | Kallmann syndrome | Enrichment | FGF17, FGF8, FGFR1, SEMA3A | 2.65 |
| 125 | Juvenile myelomonocytic leukemia | Enrichment | KRAS, NRAS, RRAS | 2.55 |
| 126 | Meningioma | Enrichment | AKT1, PDGFB, PTEN | 2.55 |
| 127 | Myopathy | Enrichment | ACTA1, COL6A1, COL6A2, COL6A3, FBN1 | 2.53 |
| 128 | Anastomosing haemangioma | Enrichment | GNA11, GNA14 | 2.50 |
| 129 | Autosomal non-syndromic agammaglobulinemia | Enrichment | BLNK, CD79A, CD79B | 2.45 |
| 130 | Ehlers-danlos syndrome, arthrochalasia type, 1 | Enrichment | COL1A1, COL1A2 | 2.45 |
| 131 | Brain small vessel disease 1 with or without ocular anomalies | Enrichment | COL4A1, COL4A2 | 2.45 |
| 132 | Brachydactyly, type a2 | Enrichment | BMP2, GDF5 | 2.45 |
| 133 | Alport syndrome 2, autosomal recessive | Enrichment | COL4A3, COL4A4 | 2.45 |
| 134 | Thyroid cancer, nonmedullary, 1 | Enrichment | BRAF, TP53 | 2.45 |
| 135 | Megalencephaly-capillary malformation-polymicrogyria syndrome | Enrichment | AKT3, PIK3R2 | 2.45 |
| 136 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 | Enrichment | AKT3, PIK3R2 | 2.45 |
| 137 | Saethre-chotzen syndrome | Enrichment | FGFR2, FGFR3 | 2.45 |
| 138 | Macular dystrophy, vitelliform, 3 | Enrichment | IMPG1, IMPG2 | 2.45 |
| 139 | Multiple synostoses syndrome | Enrichment | GDF5, GDF6 | 2.45 |
| 140 | Lung sarcomatoid carcinoma | Enrichment | KRAS, TP53 | 2.45 |
| 141 | Weill-marchesani syndrome | Enrichment | FBN1, LTBP2 | 2.45 |
| 142 | Chronic myelogenous leukemia, bcr-abl1 positive | Enrichment | KRAS, NRAS | 2.45 |
| 143 | Aortic aneurysm | Enrichment | FBN1, TGFBR1 | 2.45 |
| 144 | Noonan syndrome with multiple lentigines | Enrichment | BRAF, RAF1 | 2.45 |
| 145 | Autosomal recessive alport syndrome | Enrichment | COL4A3, COL4A4 | 2.45 |
| 146 | Osteogenesis imperfecta with normal sclerae, dominant form | Enrichment | COL1A1, COL1A2 | 2.45 |
| 147 | Diaphragmatic hernia, congenital | Enrichment | FBN1, FRAS1, FREM2 | 2.45 |
| 148 | Amelogenesis imperfecta | Enrichment | COL17A1, LAMB3, LTBP3 | 2.45 |
| 149 | Isolated macular dystrophy | Enrichment | COL4A5, IMPG1, ITGA4 | 2.35 |
| 150 | Osteogenesis imperfecta, type iii | Enrichment | BMP1, COL1A1, COL1A2 | 2.26 |
| 151 | Septopreoptic holoprosencephaly | Enrichment | CRIPTO, FGF8, GAS1 | 2.26 |
| 152 | Midline interhemispheric variant of holoprosencephaly | Enrichment | CRIPTO, FGF8, GAS1 | 2.26 |
| 153 | Hemifacial hyperplasia | Enrichment | FGFR2, FGFR3 | 2.23 |
| 154 | Macular dystrophy, vitelliform, 2 | Enrichment | IMPG1, IMPG2 | 2.23 |
| 155 | Retinal detachment | Enrichment | COL2A1, COL9A3 | 2.23 |
| 156 | Insulin-like growth factor i | Enrichment | IGF1, IGF1R | 2.23 |
| 157 | Ventricular septal defect 1 | Enrichment | BMP2, BMP7 | 2.23 |
| 158 | Holoprosencephaly | Enrichment | FGF8, FGFR1 | 2.23 |
| 159 | Juvenile glaucoma | Enrichment | EFEMP1, LTBP2 | 2.23 |
| 160 | Acute megakaryocytic leukemia | Enrichment | PTEN, TP53 | 2.23 |
| 161 | Familial porencephaly | Enrichment | COL4A1, COL4A2 | 2.23 |
| 162 | Auriculocondylar syndrome 1 | Enrichment | GNAI3, PLCB4 | 2.21 |
| 163 | Achromatopsia 4 | Enrichment | GNAI3, GNAT2 | 2.21 |
| 164 | Rhabdomyosarcoma | Enrichment | HRAS, PTEN, TP53 | 2.18 |
| 165 | Non-immune hydrops fetalis | Enrichment | ACTA1, FLT4, HRAS, KRAS | 2.16 |
| 166 | Scoliosis | Enrichment | COL2A1, CREBBP, EFEMP1, FBN1 | 2.14 |
| 167 | Atrial septal defect 1 | Enrichment | BMP2, TGFB2 | 2.07 |
| 168 | Developmental dysplasia of the hip 1 | Enrichment | COL2A1, PSMC3 | 2.07 |
| 169 | Li-fraumeni syndrome | Enrichment | MDM2, TP53 | 2.07 |
| 170 | Osteogenesis imperfecta, type i | Enrichment | COL1A1, COL1A2 | 2.07 |
| 171 | Cowden syndrome 1 | Enrichment | EGFR, PTEN | 2.07 |
| 172 | Fraser syndrome 1 | Enrichment | FRAS1, FREM2 | 2.07 |
| 173 | Holoprosencephaly 1 | Enrichment | FGF8, FGFR1 | 2.07 |
| 174 | Epidermolysis bullosa, junctional 5b, with pyloric atresia | Enrichment | ITGA6, ITGB4 | 2.07 |
| 175 | Hemangioma, capillary infantile | Enrichment | FLT4, KDR | 2.07 |
| 176 | Anterior segment dysgenesis 5 | Enrichment | BMP4, COL4A1 | 2.07 |
| 177 | Hemorrhage, intracerebral | Enrichment | COL4A1, COL4A2 | 2.07 |
| 178 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | ACTG1, COL11A1, COL11A2, KITLG, TNC | 2.04 |
| 179 | Beckwith-wiedemann syndrome | Enrichment | COL6A1, COL7A1, IGF2 | 2.03 |
| 180 | Heart, malformation of | Enrichment | COL11A2, COL2A1, MAPK1 | 2.03 |
| 181 | Osteoporosis | Enrichment | COL1A1, COL1A2, SRC | 2.01 |
| 182 | Diffuse large b-cell lymphoma | Enrichment | BRAF, PTEN, TP53 | 1.96 |
| 183 | Osteogenesis imperfecta, type ii | Enrichment | COL1A1, COL1A2 | 1.93 |
| 184 | Glanzmann thrombasthenia 1 | Enrichment | ITGA2B, ITGB3 | 1.93 |
| 185 | Gastrointestinal stromal tumor | Enrichment | KIT, PDGFRA | 1.93 |
| 186 | Capillary malformation-arteriovenous malformation 1 | Enrichment | KRAS, MAP2K1 | 1.93 |
| 187 | Leukemia, chronic myeloid | Enrichment | KRAS, NRAS | 1.93 |
| 188 | Renal cell carcinoma, papillary, 1 | Enrichment | MET, MTOR | 1.93 |
| 189 | Neuropathy, hereditary sensory and autonomic, type v | Enrichment | NGF, NTRK1 | 1.93 |
| 190 | Essential thrombocythemia | Enrichment | THPO, TP53 | 1.93 |
| 191 | Overgrowth syndrome | Enrichment | MTOR, PIK3R1 | 1.93 |
| 192 | Rare genetic intellectual disability | Enrichment | CREBBP, EP300, GNAO1 | 1.92 |
| 193 | Myeloma, multiple | Enrichment | BRAF, FGFR3, KRAS, PIK3R2, TP53 | 1.91 |
| 194 | Hepatoblastoma | Enrichment | COL7A1, FGFR3, TP53 | 1.84 |
| 195 | Melanoma, uveal | Enrichment | GNA11, PLCB4 | 1.83 |
| 196 | Rubinstein-taybi syndrome 1 | Enrichment | CREBBP, EP300 | 1.83 |
| 197 | Hemihyperplasia, isolated | Enrichment | IGF2, RHOA | 1.83 |
| 198 | Chromosome 16p13.3 deletion syndrome, proximal | Enrichment | CREBBP, EP300 | 1.83 |
| 199 | Basal ganglia calcification, idiopathic, 1 | Enrichment | PDGFB, PDGFRB | 1.81 |
| 200 | Hemochromatosis, type 1 | Enrichment | BMP2, BMP6 | 1.81 |
| 201 | Renal hypodysplasia/aplasia 1 | Enrichment | FRAS1, ITGA8 | 1.81 |
| 202 | Lymphoma, non-hodgkin, familial | Enrichment | BRAF, TP53 | 1.81 |
| 203 | Long qt syndrome 1 | Enrichment | CALM1, CALM2, CALM3, ITPR3 | 1.80 |
| 204 | Hepatocellular carcinoma | Enrichment | IGF2R, MET, TP53 | 1.79 |
| 205 | Leukemia, acute myeloid | Enrichment | KIT, KRAS, NRAS, TP53 | 1.78 |
| 206 | Brittle bone disorder | Enrichment | BMP1, COL1A1, COL1A2 | 1.73 |
| 207 | Inflammatory bowel disease 1 | Enrichment | IL6, PRKCQ | 1.71 |
| 208 | Arteriovenous malformation | Enrichment | HRAS, MAP2K1 | 1.71 |
| 209 | Adult hepatocellular carcinoma | Enrichment | EGF, TP53 | 1.71 |
| 210 | Primary hyperaldosteronism | Enrichment | BRAF, TP53 | 1.71 |
| 211 | Cowden syndrome | Enrichment | AKT1, PTEN | 1.71 |
| 212 | Familial thoracic aortic aneurysm and dissection | Enrichment | COL3A1, FBN1 | 1.71 |
| 213 | Renal agenesis, bilateral | Enrichment | FGF20, ITGA8 | 1.71 |
| 214 | Microcephaly | Enrichment | COL4A1, COL7A1, EP300, GNAO1, GNB1, HDAC8, IGF1R, MAPK1, PLA2G6 | 1.70 |
| 215 | Oligoarticular juvenile idiopathic arthritis | Enrichment | CD247, IL2RA | 1.69 |
| 216 | Rheumatoid factor-negative juvenile idiopathic arthritis | Enrichment | CD247, IL2RA | 1.69 |
| 217 | Gastric cancer | Enrichment | FGFR2, KRAS, PTEN, TP53 | 1.67 |
| 218 | Hereditary breast carcinoma | Enrichment | AKT1, KRAS, PTEN, TP53 | 1.64 |
| 219 | Peters-plus syndrome | Enrichment | BMP4, COL4A1 | 1.62 |
| 220 | Stroke, ischemic | Enrichment | FBN1, PRKCH | 1.62 |
| 221 | Myopathy, x-linked, with excessive autophagy | Enrichment | HRAS, MAP2K1 | 1.62 |
| 222 | Polymicrogyria | Enrichment | AKT3, PSMC3 | 1.62 |
| 223 | Autosomal dominant macrothrombocytopenia | Enrichment | ITGA2B, ITGB3 | 1.62 |
| 224 | Stickler syndrome, type i | Enrichment | COL2A1 | 1.61 |
| 225 | Bladder diverticulum | Enrichment | EFEMP1 | 1.61 |
| 226 | Cryptophthalmos, unilateral or bilateral, isolated | Enrichment | FREM2 | 1.61 |
| 227 | Short stature and advanced bone age with or without early-onset osteoarthritis and/or osteochondritis dissecans | Enrichment | ACAN | 1.61 |
| 228 | Hypochondroplasia | Enrichment | FGFR3 | 1.61 |
| 229 | Proteus syndrome | Enrichment | AKT1 | 1.61 |
| 230 | Beare-stevenson cutis gyrata syndrome | Enrichment | FGFR2 | 1.61 |
| 231 | Ectopia lentis 1, isolated, autosomal dominant | Enrichment | FBN1 | 1.61 |
| 232 | Epidermolysis bullosa dystrophica, pretibial | Enrichment | COL7A1 | 1.61 |
| 233 | Epidermolysis bullosa dystrophica, autosomal dominant | Enrichment | COL7A1 | 1.61 |
| 234 | Osteoglophonic dysplasia | Enrichment | FGFR1 | 1.61 |
| 235 | Epiphyseal dysplasia, multiple, with myopia and conductive deafness | Enrichment | COL2A1 | 1.61 |
| 236 | Thanatophoric dysplasia, type i | Enrichment | FGFR3 | 1.61 |
| 237 | Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma | Enrichment | LTBP2 | 1.61 |
| 238 | Trigonocephaly 1 | Enrichment | FGFR1 | 1.61 |
| 239 | Hypoinsulinemic hypoglycemia with hemihypertrophy | Enrichment | AKT2 | 1.61 |
| 240 | Ehlers-danlos syndrome, cardiac valvular type | Enrichment | COL1A2 | 1.61 |
| 241 | Epidermolysis bullosa dystrophica, autosomal recessive | Enrichment | COL7A1 | 1.61 |
| 242 | Spondylometaphyseal dysplasia, algerian type | Enrichment | COL2A1 | 1.61 |
| 243 | Spinocerebellar ataxia 27a | Enrichment | FGF14 | 1.61 |
| 244 | Baraitser-winter syndrome 1 | Enrichment | ACTB | 1.61 |
| 245 | Oculoectodermal syndrome | Enrichment | KRAS | 1.61 |
| 246 | Muenke syndrome | Enrichment | FGFR3 | 1.61 |
| 247 | Vacterl association with hydrocephalus | Enrichment | PTEN | 1.61 |
| 248 | Pallister-killian syndrome | Enrichment | ARAF | 1.61 |
| 249 | Premature aging syndrome, penttinen type | Enrichment | PDGFRB | 1.61 |
| 250 | Alport syndrome 1, x-linked | Enrichment | COL4A5 | 1.61 |
| 251 | Type 1 diabetes mellitus 10 | Enrichment | IL2RA | 1.61 |
| 252 | Deafness, autosomal recessive 53 | Enrichment | COL11A2 | 1.61 |
| 253 | Systemic lupus erythematosus 6 | Enrichment | ITGAM | 1.61 |
| 254 | Cornelia de lange syndrome 3 with or without midline brain defects | Enrichment | SMC3 | 1.61 |
| 255 | Osteoarthritis with mild chondrodysplasia | Enrichment | COL2A1 | 1.61 |
| 256 | Avascular necrosis of femoral head, primary, 1 | Enrichment | COL2A1 | 1.61 |
| 257 | Noonan syndrome 5 | Enrichment | RAF1 | 1.61 |
| 258 | Hypomagnesemia 4, renal | Enrichment | EGF | 1.61 |
| 259 | Czech dysplasia | Enrichment | COL2A1 | 1.61 |
| 260 | Glaucoma 3, primary congenital, d | Enrichment | LTBP2 | 1.61 |
| 261 | Microphthalmia, isolated 4 | Enrichment | GDF6 | 1.61 |
| 262 | Angel-shaped phalangoepiphyseal dysplasia | Enrichment | GDF5 | 1.61 |
| 263 | Noonan syndrome 4 | Enrichment | SOS1 | 1.61 |
| 264 | Nail disorder, nonsyndromic congenital, 8 | Enrichment | COL7A1 | 1.61 |
| 265 | Hypereosinophilic syndrome, idiopathic | Enrichment | PDGFRA | 1.61 |
| 266 | Glaucoma 1, open angle, h | Enrichment | EFEMP1 | 1.61 |
| 267 | Immunodeficiency 73a with defective neutrophil chemotaxis and leukocytosis | Enrichment | RAC2 | 1.61 |
| 268 | Deafness, autosomal recessive 39 | Enrichment | HGF | 1.61 |
| 269 | Corneal dystrophy, posterior polymorphous, 2 | Enrichment | COL8A2 | 1.61 |
| 270 | Mastocytosis, cutaneous | Enrichment | KIT | 1.61 |
| 271 | Scaphocephaly, maxillary retrusion, and impaired intellectual development | Enrichment | FGFR2 | 1.61 |
| 272 | Marshall syndrome | Enrichment | COL11A1 | 1.61 |
| 273 | Congenital myopathy 2a, typical, autosomal dominant | Enrichment | ACTA1 | 1.61 |
| 274 | Melorheostosis, isolated | Enrichment | MAP2K1 | 1.61 |
| 275 | Kniest dysplasia | Enrichment | COL2A1 | 1.61 |
| 276 | Noonan syndrome 7 | Enrichment | BRAF | 1.61 |
| 277 | Leopard syndrome 3 | Enrichment | BRAF | 1.61 |
| 278 | Apert syndrome | Enrichment | FGFR2 | 1.61 |
| 279 | Cardiomyopathy, dilated, 1jj | Enrichment | LAMA4 | 1.61 |
| 280 | Transient bullous dermolysis of the newborn | Enrichment | COL7A1 | 1.61 |
| 281 | Basal ganglia calcification, idiopathic, 5 | Enrichment | PDGFB | 1.61 |
| 282 | Hyperpigmentation with or without hypopigmentation, familial progressive | Enrichment | KITLG | 1.61 |
| 283 | Corneal dystrophy, fuchs endothelial, 1 | Enrichment | COL8A2 | 1.61 |
| 284 | Platyspondylic lethal skeletal dysplasia, torrance type | Enrichment | COL2A1 | 1.61 |
| 285 | Cardiomyopathy, dilated, 1nn | Enrichment | RAF1 | 1.61 |
| 286 | Epidermolysis bullosa with congenital localized absence of skin and deformity of nails | Enrichment | COL7A1 | 1.61 |
| 287 | Multiple self-healing squamous epithelioma | Enrichment | TGFBR1 | 1.61 |
| 288 | Cardiofaciocutaneous syndrome 3 | Enrichment | MAP2K1 | 1.61 |
| 289 | Myofibromatosis, infantile, 1 | Enrichment | PDGFRB | 1.61 |
| 290 | Fibrochondrogenesis 1 | Enrichment | COL11A1 | 1.61 |
| 291 | Melanosis, neurocutaneous | Enrichment | NRAS | 1.61 |
| 292 | Lipoid proteinosis of urbach and wiethe | Enrichment | ECM1 | 1.61 |
| 293 | Thanatophoric dysplasia, type ii | Enrichment | FGFR3 | 1.61 |
| 294 | Noonan syndrome 9 | Enrichment | SOS2 | 1.61 |
| 295 | Spondyloepiphyseal dysplasia, stanescu type | Enrichment | COL2A1 | 1.61 |
| 296 | Myopathy, scapulohumeroperoneal | Enrichment | ACTA1 | 1.61 |
| 297 | Noonan syndrome 6 | Enrichment | NRAS | 1.61 |
| 298 | Lissencephaly 5 | Enrichment | LAMB1 | 1.61 |
| 299 | Weill-marchesani syndrome 2 | Enrichment | FBN1 | 1.61 |
| 300 | Hypogonadotropic hypogonadism 20 with or without anosmia | Enrichment | FGF17 | 1.61 |
| 301 | Retinitis pigmentosa 56 | Enrichment | IMPG2 | 1.61 |
| 302 | Ciliary dyskinesia, primary, 33 | Enrichment | DRC4 | 1.61 |
| 303 | Deafness, autosomal dominant 56 | Enrichment | TNC | 1.61 |
| 304 | Gist-plus syndrome | Enrichment | PDGFRA | 1.61 |
| 305 | Camptodactyly, tall stature, and hearing loss syndrome | Enrichment | FGFR3 | 1.61 |
| 306 | Ataxia-oculomotor apraxia 3 | Enrichment | PIK3R5 | 1.61 |
| 307 | Hypogonadotropic hypogonadism 23 with or without anosmia | Enrichment | LHB | 1.61 |
| 308 | Geleophysic dysplasia 2 | Enrichment | FBN1 | 1.61 |
| 309 | Accelerated tumor formation | Enrichment | MDM2 | 1.61 |
| 310 | Protrusio acetabuli | Enrichment | FBN1 | 1.61 |
| 311 | Aplasia of lacrimal and salivary glands | Enrichment | FGF10 | 1.61 |
| 312 | Autoimmune lymphoproliferative syndrome, type iii | Enrichment | PRKCD | 1.61 |
| 313 | Bent bone dysplasia syndrome 1 | Enrichment | FGFR2 | 1.61 |
| 314 | Acrogeria, gottron type | Enrichment | COL3A1 | 1.61 |
| 315 | Epiphyseal dysplasia, multiple, 6 | Enrichment | COL9A1 | 1.61 |
| 316 | Weill-marchesani syndrome 3 | Enrichment | LTBP2 | 1.61 |
| 317 | Achondrogenesis, type ii | Enrichment | COL2A1 | 1.61 |
| 318 | Noonan syndrome 11 | Enrichment | MRAS | 1.61 |
| 319 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 | Enrichment | ACTG2 | 1.61 |
| 320 | Noonan syndrome 13 | Enrichment | MAPK1 | 1.61 |
| 321 | Macular degeneration, early-onset | Enrichment | FBN2 | 1.61 |
| 322 | Macular dystrophy, vitelliform, 4 | Enrichment | IMPG1 | 1.61 |
| 323 | Fraser syndrome 2 | Enrichment | FREM2 | 1.61 |
| 324 | Neurodevelopmental disorder with microcephaly, hypotonia, and absent language | Enrichment | PSMB1 | 1.61 |
| 325 | Nephrotic syndrome, type 26 | Enrichment | LAMA5 | 1.61 |
| 326 | Developmental and epileptic encephalopathy 58 | Enrichment | NTRK2 | 1.61 |
| 327 | Multiple synostoses syndrome 4 | Enrichment | GDF6 | 1.61 |
| 328 | Myasthenic syndrome, congenital, 19 | Enrichment | COL13A1 | 1.61 |
| 329 | Deafness, x-linked 6 | Enrichment | COL4A6 | 1.61 |
| 330 | Intellectual developmental disorder, x-linked 110 | Enrichment | FGF13 | 1.61 |
| 331 | Spinocerebellar ataxia 27b, late-onset | Enrichment | FGF14 | 1.61 |
| 332 | Epiphyseal dysplasia, multiple, 2 | Enrichment | COL9A2 | 1.61 |
| 333 | Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies | Enrichment | RAC3 | 1.61 |
| 334 | Lessel-kubisch syndrome | Enrichment | MDM2 | 1.61 |
| 335 | Ullrich congenital muscular dystrophy 1b | Enrichment | COL6A2 | 1.61 |
| 336 | Hyperemesis gravidarum | Enrichment | GDF15 | 1.61 |
| 337 | Cutis laxa, autosomal recessive, type id | Enrichment | EFEMP1 | 1.61 |
| 338 | Amegakaryocytic thrombocytopenia, congenital, 2 | Enrichment | THPO | 1.61 |
| 339 | Deafness, autosomal recessive 125 | Enrichment | GAS2 | 1.61 |
| 340 | Short syndrome | Enrichment | PIK3R1 | 1.61 |
| 341 | Bone marrow failure syndrome 5 | Enrichment | TP53 | 1.61 |
| 342 | Fetomaternal alloimmune thrombocytopenia 2 | Enrichment | ITGA2B | 1.61 |
| 343 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 2 | Enrichment | COL1A2 | 1.61 |
| 344 | Hereditary lymphedema id | Enrichment | VEGFC | 1.61 |
| 345 | Congenital smooth muscle hamartoma, with or without hemihypertrophy | Enrichment | ACTB | 1.61 |
| 346 | Immune dysregulation, autoimmunity, and autoinflammation | Enrichment | PLCG1 | 1.61 |
| 347 | Osteofibrous dysplasia | Enrichment | MET | 1.61 |
| 348 | Complete cryptophthalmia | Enrichment | FREM2 | 1.61 |
| 349 | Papilloma of choroid plexus | Enrichment | TP53 | 1.61 |
| 350 | Microphthalmia, syndromic 6 | Enrichment | BMP4 | 1.61 |
| 351 | Spondyloperipheral dysplasia | Enrichment | COL2A1 | 1.61 |
| 352 | Myosclerosis, autosomal recessive | Enrichment | COL6A2 | 1.61 |
| 353 | Basal cell carcinoma 7 | Enrichment | TP53 | 1.61 |
| 354 | Porencephaly | Enrichment | COL4A1 | 1.61 |
| 355 | Ullrich congenital muscular dystrophy 1c | Enrichment | COL6A3 | 1.61 |
| 356 | Deafness, autosomal dominant 37 | Enrichment | COL11A1 | 1.61 |
| 357 | Lymphoplasmacytic lymphoma | Enrichment | FBN1 | 1.61 |
| 358 | Myeloid and lymphoid neoplasms associated with pdgfra rearrangement | Enrichment | PDGFRA | 1.61 |
| 359 | Immunodeficiency 73c with defective neutrophil chemotaxis and hypogammaglobulinemia | Enrichment | RAC2 | 1.61 |
| 360 | Anaplastic thyroid carcinoma | Enrichment | TP53 | 1.61 |
| 361 | Developmental and epileptic encephalopathy 90 | Enrichment | FGF13 | 1.61 |
| 362 | Orofacial cleft 11 | Enrichment | BMP4 | 1.61 |
| 363 | Metacarpal 4-5 fusion | Enrichment | FGF16 | 1.61 |
| 364 | Epiphyseal dysplasia, multiple, 3 | Enrichment | COL9A3 | 1.61 |
| 365 | Lymphatic malformation 4 | Enrichment | VEGFC | 1.61 |
| 366 | Papillary tumor of the pineal region | Enrichment | PTEN | 1.61 |
| 367 | Lacrimoauriculodentodigital syndrome 3 | Enrichment | FGF10 | 1.61 |
| 368 | Familial isolated trichomegaly | Enrichment | FGF5 | 1.61 |
| 369 | Cardiofaciocutaneous syndrome 2 | Enrichment | KRAS | 1.61 |
| 370 | Spondyloepimetaphyseal dysplasia, aggrecan type | Enrichment | ACAN | 1.61 |
| 371 | Deafness, cataract, impaired intellectual development, and polyneuropathy | Enrichment | PSMC3 | 1.61 |
| 372 | Deafness, autosomal dominant 13 | Enrichment | COL11A2 | 1.61 |
| 373 | Deafness, autosomal recessive 97 | Enrichment | MET | 1.61 |
| 374 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 | Enrichment | AKT3 | 1.61 |
| 375 | Lymphangioma | Enrichment | BRAF | 1.61 |
| 376 | Skin/hair/eye pigmentation, variation in, 7 | Enrichment | KITLG | 1.61 |
| 377 | Crouzon syndrome with acanthosis nigricans | Enrichment | FGFR3 | 1.61 |
| 378 | Camurati-engelmann disease 2 | Enrichment | TGFB2 | 1.61 |
| 379 | Geleophysic dysplasia 3 | Enrichment | LTBP3 | 1.61 |
| 380 | Spondyloepiphyseal dysplasia, kimberley type | Enrichment | ACAN | 1.61 |
| 381 | Phace association | Enrichment | BRAF | 1.61 |
| 382 | Spinocerebellar ataxia 14 | Enrichment | PRKCG | 1.61 |
| 383 | Epidermolysis bullosa pruriginosa | Enrichment | COL7A1 | 1.61 |
| 384 | Becker nevus syndrome | Enrichment | ACTB | 1.61 |
| 385 | Melorheostosis | Enrichment | MAP2K1 | 1.61 |
| 386 | Dystonia-deafness syndrome 1 | Enrichment | ACTB | 1.61 |
| 387 | Autism 9 | Enrichment | MET | 1.61 |
| 388 | Stickler syndrome, type i, nonsyndromic ocular | Enrichment | COL2A1 | 1.61 |
| 389 | Visceral neuropathy, familial, 3, autosomal dominant | Enrichment | ACTG2 | 1.61 |
| 390 | Leopard syndrome 2 | Enrichment | RAF1 | 1.61 |
| 391 | Stickler syndrome, type iv | Enrichment | COL9A1 | 1.61 |
| 392 | Glaucoma 1, open angle, o | Enrichment | NTF4 | 1.61 |
| 393 | Cortical malformations, occipital | Enrichment | LAMC3 | 1.61 |
| 394 | Iron overload | Enrichment | BMP6 | 1.61 |
| 395 | Congenital myopathy 2b, severe infantile, autosomal recessive | Enrichment | ACTA1 | 1.61 |
| 396 | Basal ganglia calcification, idiopathic, 4 | Enrichment | PDGFRB | 1.61 |
| 397 | Immunodeficiency 36 with lymphoproliferation | Enrichment | PIK3R1 | 1.61 |
| 398 | Hypogonadotropic hypogonadism 12 with or without anosmia | Enrichment | GNRH1 | 1.61 |
| 399 | Cardiofaciocutaneous syndrome 4 | Enrichment | MAP2K2 | 1.61 |
| 400 | Autoinflammation, antibody deficiency, and immune dysregulation | Enrichment | PLCG2 | 1.61 |
| 401 | Hypogonadotropic hypogonadism 16 with or without anosmia | Enrichment | SEMA3A | 1.61 |
| 402 | Leber congenital amaurosis 17 | Enrichment | GDF6 | 1.61 |
| 403 | Cowden syndrome 6 | Enrichment | AKT1 | 1.61 |
| 404 | Telangiectasia, hereditary hemorrhagic, type 5 | Enrichment | GDF2 | 1.61 |
| 405 | Hereditary thrombocytosis with transverse limb defect | Enrichment | THPO | 1.61 |
| 406 | Fibrochondrogenesis 2 | Enrichment | COL11A2 | 1.61 |
| 407 | Dystonia 27 | Enrichment | COL6A3 | 1.61 |
| 408 | Myeloid and lymphoid neoplasms associated with pdgfrb rearrangement | Enrichment | PDGFRB | 1.61 |
| 409 | Autosomal dominant familial visceral neuropathy | Enrichment | ACTG2 | 1.61 |
| 410 | Agammaglobulinemia 7, autosomal recessive | Enrichment | PIK3R1 | 1.61 |
| 411 | Thyroid gland disease | Enrichment | COL7A1 | 1.61 |
| 412 | Hypogonadotropic hypogonadism 6 with or without anosmia | Enrichment | FGF8 | 1.61 |
| 413 | Obesity, hyperphagia, and developmental delay | Enrichment | NTRK2 | 1.61 |
| 414 | Glioma susceptibility 2 | Enrichment | PTEN | 1.61 |
| 415 | Achondroplasia, severe, with developmental delay and acanthosis nigricans | Enrichment | FGFR3 | 1.61 |
| 416 | Ductal carcinoma in situ | Enrichment | TP53 | 1.61 |
| 417 | Kosaki overgrowth syndrome | Enrichment | PDGFRB | 1.61 |
| 418 | Familial cold autoinflammatory syndrome 3 | Enrichment | PLCG2 | 1.61 |
| 419 | Congenital heart defects and ectodermal dysplasia | Enrichment | PRKD1 | 1.61 |
| 420 | Stickler syndrome, type v | Enrichment | COL9A2 | 1.61 |
| 421 | Tumoral calcinosis, hyperphosphatemic, familial, 2 | Enrichment | FGF23 | 1.61 |
| 422 | Hartsfield syndrome | Enrichment | FGFR1 | 1.61 |
| 423 | Congenital heart defects, multiple types, 7 | Enrichment | FLT4 | 1.61 |
| 424 | Loeys-dietz syndrome 5 | Enrichment | TGFB3 | 1.61 |
| 425 | Renal hypodysplasia/aplasia 2 | Enrichment | FGF20 | 1.61 |
| 426 | Macular dystrophy, vitelliform, 5 | Enrichment | IMPG2 | 1.61 |
| 427 | 20p12.3 microdeletion syndrome | Enrichment | BMP2 | 1.61 |
| 428 | Cutis laxa, autosomal recessive, type iie | Enrichment | LTBP1 | 1.61 |
| 429 | Takenouchi-kosaki syndrome | Enrichment | CDC42 | 1.61 |
| 430 | Congenital myopathy 2c, severe infantile, autosomal dominant | Enrichment | ACTA1 | 1.61 |
| 431 | Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 | Enrichment | BMP2 | 1.61 |
| 432 | Thrombocytopenia 8, with dysmorphic features and developmental delay | Enrichment | ACTB | 1.61 |
| 433 | Qualitative or quantitative defects of collagen 6 | Enrichment | COL6A2 | 1.61 |
| 434 | Developmental and epileptic encephalopathy 47 | Enrichment | FGF12 | 1.61 |
| 435 | Ocular pterygium-digital keloid dysplasia syndrome | Enrichment | PDGFRB | 1.61 |
| 436 | Immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia | Enrichment | RAC2 | 1.61 |
| 437 | Chronic mast cell leukemia | Enrichment | KIT | 1.61 |
| 438 | Premature ovarian failure 14 | Enrichment | GDF9 | 1.61 |
| 439 | Trigonitis | Enrichment | RAF1 | 1.61 |
| 440 | Bent bone dysplasia syndrome 2 | Enrichment | LAMA5 | 1.61 |
| 441 | Vitreoretinopathy with phalangeal epiphyseal dysplasia | Enrichment | COL2A1 | 1.61 |
| 442 | Recessive dystrophic epidermolysis bullosa-generalized other | Enrichment | COL7A1 | 1.61 |
| 443 | Thyroid gland undifferentiated carcinoma | Enrichment | TP53 | 1.61 |
| 444 | Tufted angioma of skin | Enrichment | KDR | 1.61 |
| 445 | Asphyxia neonatorum | Enrichment | COL1A1 | 1.61 |
| 446 | Deafness, autosomal dominant 69 | Enrichment | KITLG | 1.61 |
| 447 | Bethlem myopathy 1b | Enrichment | COL6A2 | 1.61 |
| 448 | Small-cell carcinoma of the ovary of hypercalcemic type | Enrichment | TP53 | 1.61 |
| 449 | Thrombocytopenia 9 | Enrichment | THPO | 1.61 |
| 450 | Fibrosis of extraocular muscles, congenital, 5 | Enrichment | COL25A1 | 1.61 |
| 451 | Arthrogryposis, distal, type 11 | Enrichment | MET | 1.61 |
| 452 | Amelogenesis imperfecta, type ih | Enrichment | ITGB6 | 1.61 |
| 453 | Lacrimoauriculodentodigital syndrome 2 | Enrichment | FGFR3 | 1.61 |
| 454 | Baraitser-winter syndrome | Enrichment | ACTB | 1.61 |
| 455 | Late-onset junctional epidermolysis bullosa | Enrichment | COL17A1 | 1.61 |
| 456 | Col4a1-related disorders | Enrichment | COL4A1 | 1.61 |
| 457 | Occipital pachygyria and polymicrogyria | Enrichment | LAMC3 | 1.61 |
| 458 | Short-rib thoracic dysplasia 22 without polydactyly | Enrichment | FGF4 | 1.61 |
| 459 | Bethlem myopathy 1c | Enrichment | COL6A3 | 1.61 |
| 460 | Retinal lattice degeneration | Enrichment | COL9A3 | 1.61 |
| 461 | Capillary hemangioma | Enrichment | AKT3 | 1.61 |
| 462 | Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtype | Enrichment | TP53 | 1.61 |
| 463 | Glaucoma secondary to spherophakia/ectopia lentis and megalocornea | Enrichment | LTBP2 | 1.61 |
| 464 | Anus disease | Enrichment | FREM2 | 1.61 |
| 465 | Isolated bone marrow mastocytosis | Enrichment | KIT | 1.61 |
| 466 | Congenital pulmonary airway malformation | Enrichment | KRAS | 1.61 |
| 467 | Autosomal dominant rhegmatogenous retinal detachment | Enrichment | COL2A1 | 1.61 |
| 468 | Smoldering systemic mastocytosis | Enrichment | KIT | 1.61 |
| 469 | Choroid plexus cancer | Enrichment | TP53 | 1.61 |
| 470 | Fetomaternal alloimmune thrombocytopenia 3 | Enrichment | ITGA2 | 1.61 |
| 471 | Col4a1 or col4a2-related cerebral small vessel disease | Enrichment | COL4A1 | 1.61 |
| 472 | Multiple epiphyseal dysplasia with myopia and deafness | Enrichment | COL2A1 | 1.61 |
| 473 | Immune dysregulation, neurodevelopmental defects, and colitis | Enrichment | ITGAV | 1.61 |
| 474 | Zebra body myopathy | Enrichment | ACTA1 | 1.61 |
| 475 | Spinocerebellar ataxia type 27b | Enrichment | FGF14 | 1.61 |
| 476 | Hypochondrogenesis | Enrichment | COL2A1 | 1.61 |
| 477 | Infantile lad-like disease due to rac2 deficiency | Enrichment | RAC2 | 1.61 |
| 478 | Fgfr3-related chondrodysplasia | Enrichment | FGFR3 | 1.61 |
| 479 | Congenital smooth muscle hamartoma | Enrichment | ACTB | 1.61 |
| 480 | X-linked alport syndrome | Enrichment | COL4A5 | 1.61 |
| 481 | Pneumothorax | Enrichment | COL5A1 | 1.61 |
| 482 | Reticular dysgenesis-like severe combined immunodeficiency | Enrichment | RAC2 | 1.61 |
| 483 | Nocarh syndrome | Enrichment | CDC42 | 1.61 |
| 484 | Mastocytosis | Enrichment | KIT | 1.61 |
| 485 | Congenital primary lymphedema of gordon | Enrichment | VEGFC | 1.61 |
| 486 | Syringocystadenoma papilliferum | Enrichment | BRAF | 1.61 |
| 487 | Localized dystrophic epidermolysis bullosa, acral form | Enrichment | COL7A1 | 1.61 |
| 488 | Developmental malformations-deafness-dystonia syndrome | Enrichment | ACTB | 1.61 |
| 489 | Osteochondritis dissecans | Enrichment | ACAN | 1.61 |
| 490 | Camptodactyly-tall stature-scoliosis-hearing loss syndrome | Enrichment | FGFR3 | 1.61 |
| 491 | Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome | Enrichment | COL11A1 | 1.61 |
| 492 | Familial progressive hyperpigmentation | Enrichment | KITLG | 1.61 |
| 493 | Dysspondyloenchondromatosis | Enrichment | COL2A1 | 1.61 |
| 494 | Cystic lymphangioma | Enrichment | COL11A2 | 1.61 |
| 495 | Pleomorphic xanthoastrocytoma | Enrichment | TP53 | 1.61 |
| 496 | Ganglioglioma | Enrichment | BRAF | 1.61 |
| 497 | Abdominal aortic aneurysm | Enrichment | COL3A1 | 1.61 |
| 498 | Cutaneous mastocytoma | Enrichment | KIT | 1.61 |
| 499 | Nongerminomatous germ cell tumor | Enrichment | BRAF | 1.61 |
| 500 | Lethal arteriopathy syndrome due to fibulin-4 deficiency | Enrichment | EFEMP2 | 1.61 |
| 501 | Phace syndrome | Enrichment | BRAF | 1.61 |
| 502 | Neonatal marfan syndrome | Enrichment | FBN1 | 1.61 |
| 503 | Recessive dystrophic epidermolysis bullosa inversa | Enrichment | COL7A1 | 1.61 |
| 504 | Typical urticaria pigmentosa | Enrichment | KIT | 1.61 |
| 505 | Phakomatosis pigmentokeratotica | Enrichment | HRAS | 1.61 |
| 506 | Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome | Enrichment | PTEN | 1.61 |
| 507 | Actin-accumulation myopathy | Enrichment | ACTA1 | 1.61 |
| 508 | Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom | Enrichment | RAC1 | 1.61 |
| 509 | Classic hairy cell leukemia | Enrichment | BRAF | 1.61 |
| 510 | Nodular urticaria pigmentosa | Enrichment | KIT | 1.61 |
| 511 | Malignant epithelial tumor of salivary glands | Enrichment | PRKD1 | 1.61 |
| 512 | Type 2 collagen-related bone disorder | Enrichment | COL2A1 | 1.61 |
| 513 | Hartsfield-bixler-demyer syndrome | Enrichment | FGFR1 | 1.61 |
| 514 | Pseudoxanthomatous diffuse cutaneous mastocytosis | Enrichment | KIT | 1.61 |
| 515 | Lama5-related multisystemic syndrome | Enrichment | LAMA5 | 1.61 |
| 516 | Telangiectasia macularis eruptiva perstans | Enrichment | KIT | 1.61 |
| 517 | Acute mast cell leukemia | Enrichment | KIT | 1.61 |
| 518 | Myopathic intestinal pseudoobstruction | Enrichment | ACTG2 | 1.61 |
| 519 | Rac2-related combined immunodeficiency-bronchiectasis-cancer-predisposing syndrome | Enrichment | RAC2 | 1.61 |
| 520 | Short stature-advanced bone age-early-onset osteoarthritis syndrome | Enrichment | ACAN | 1.61 |
| 521 | Cryptophthalmia | Enrichment | FREM2 | 1.61 |
| 522 | Egf-related primary hypomagnesemia with intellectual disability | Enrichment | EGF | 1.61 |
| 523 | Non-syndromic unicoronal craniosynostosis | Enrichment | FGFR2 | 1.61 |
| 524 | Familial progressive hyper- and hypopigmentation | Enrichment | KITLG | 1.61 |
| 525 | Plaque-form urticaria pigmentosa | Enrichment | KIT | 1.61 |
| 526 | Interstitial lung disease specific to childhood | Enrichment | FGF10 | 1.61 |
| 527 | Generalized dominant dystrophic epidermolysis bullosa | Enrichment | COL7A1 | 1.61 |
| 528 | Neurocutaneous melanocytosis | Enrichment | NRAS | 1.61 |
| 529 | Bullous diffuse cutaneous mastocytosis | Enrichment | KIT | 1.61 |
| 530 | Actg2 visceral myopathy | Enrichment | ACTG2 | 1.61 |
| 531 | Laminin subunit alpha 2-related muscular dystrophy | Enrichment | LAMA2 | 1.61 |
| 532 | Akt2-related familial partial lipodystrophy | Enrichment | AKT2 | 1.61 |
| 533 | Testis seminoma | Enrichment | KIT | 1.61 |
| 534 | Hydrops fetalis, nonimmune | Enrichment | ACTA1, FLT4, HRAS | 1.59 |
| 535 | Gastroesophageal reflux | Enrichment | COL5A1, RPS6KA3 | 1.58 |
| 536 | Spastic paraplegia 4, autosomal dominant | Enrichment | COL3A1, GNAS | 1.58 |
| 537 | Focal segmental glomerulosclerosis | Enrichment | COL4A4, COL4A5, PLCE1 | 1.58 |
| 538 | Hypertelorism | Enrichment | COL11A1, COL1A1, ELN, FGFR2, RPS6KA3 | 1.56 |
| 539 | Pectus excavatum | Enrichment | FBN1, TGFBR1 | 1.54 |
| 540 | Meningioma, familial | Enrichment | PDGFB, PTEN | 1.54 |
| 541 | Presynaptic congenital myasthenic syndromes | Enrichment | COL13A1, LAMA5 | 1.54 |
| 542 | Anhidrosis, isolated, with normal sweat glands | Enrichment | ITPR2 | 1.48 |
| 543 | Hypocalciuric hypercalcemia, familial, type ii | Enrichment | GNA11 | 1.48 |
| 544 | Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia | Enrichment | HDAC6 | 1.48 |
| 545 | Coffin-lowry syndrome | Enrichment | RPS6KA3 | 1.48 |
| 546 | Developmental and epileptic encephalopathy 8 | Enrichment | ARHGEF9 | 1.48 |
| 547 | Osteopetrosis and infantile neuroaxonal dystrophy | Enrichment | PLA2G6 | 1.48 |
| 548 | Pseudohypoparathyroidism, type ic | Enrichment | GNAS | 1.48 |
| 549 | Osseous heteroplasia, progressive | Enrichment | GNAS | 1.48 |
| 550 | Nail disorder, nonsyndromic congenital, 3 | Enrichment | PLCD1 | 1.48 |
| 551 | Cardiac valvular dysplasia 1 | Enrichment | PLD1 | 1.48 |
| 552 | Fleck retina, familial benign | Enrichment | PLA2G5 | 1.48 |
| 553 | Dyskinesia with orofacial involvement, autosomal dominant | Enrichment | ADCY5 | 1.48 |
| 554 | Neurodevelopmental disorder with involuntary movements | Enrichment | GNAO1 | 1.48 |
| 555 | Deafness, autosomal recessive 44 | Enrichment | ADCY1 | 1.48 |
| 556 | Agammaglobulinemia 3, autosomal recessive | Enrichment | CD79A | 1.48 |
| 557 | Ventricular tachycardia, familial | Enrichment | GNAI2 | 1.48 |
| 558 | Acth-independent macronodular adrenal hyperplasia 1 | Enrichment | GNAS | 1.48 |
| 559 | Immunodeficiency 62 | Enrichment | ARHGEF1 | 1.48 |
| 560 | Hiatt-neu-cooper neurodevelopmental syndrome | Enrichment | RALA | 1.48 |
| 561 | Neurodevelopmental disorder with hypotonia and dysmorphic facies | Enrichment | GNB2 | 1.48 |
| 562 | Neurodevelopmental disorder with midbrain and hindbrain malformations | Enrichment | ARHGEF2 | 1.48 |
| 563 | Spondylometaphyseal dysplasia with corneal dystrophy | Enrichment | PLCB3 | 1.48 |
| 564 | Immunodeficiency 81 | Enrichment | LCP2 | 1.48 |
| 565 | Immunodeficiency 82 with systemic inflammation | Enrichment | SYK | 1.48 |
| 566 | Neurodevelopmental disorder with hyperkinetic movements and dyskinesia | Enrichment | ADCY5 | 1.48 |
| 567 | Pituitary adenoma 3, multiple types | Enrichment | GNAS | 1.48 |
| 568 | Neurodegeneration with brain iron accumulation 2a | Enrichment | PLA2G6 | 1.48 |
| 569 | Charcot-marie-tooth disease, demyelinating, type 1j | Enrichment | ITPR3 | 1.48 |
| 570 | Auriculocondylar syndrome 4 | Enrichment | HDAC9 | 1.48 |
| 571 | Developmental and epileptic encephalopathy 91 | Enrichment | PPP3CA | 1.48 |
| 572 | Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development | Enrichment | PPP3CA | 1.48 |
| 573 | Cornelia de lange syndrome 5 | Enrichment | HDAC8 | 1.48 |
| 574 | Immunodeficiency 48 | Enrichment | ZAP70 | 1.48 |
| 575 | Auriculocondylar syndrome 2a | Enrichment | PLCB4 | 1.48 |
| 576 | Isolated growth hormone deficiency type iii | Enrichment | BTK | 1.48 |
| 577 | Intellectual developmental disorder, x-linked 46 | Enrichment | ARHGEF6 | 1.48 |
| 578 | Intellectual developmental disorder, x-linked 19 | Enrichment | RPS6KA3 | 1.48 |
| 579 | Immunodeficiency 18 | Enrichment | CD3E | 1.48 |
| 580 | Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language | Enrichment | MEF2C | 1.48 |
| 581 | Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities | Enrichment | GNAI1 | 1.48 |
| 582 | Slowed nerve conduction velocity, autosomal dominant | Enrichment | ARHGEF10 | 1.48 |
| 583 | Developmental and epileptic encephalopathy 17 | Enrichment | GNAO1 | 1.48 |
| 584 | Dyskinesia with orofacial involvement, autosomal recessive | Enrichment | ADCY5 | 1.48 |
| 585 | Immunodeficiency 25 | Enrichment | CD247 | 1.48 |
| 586 | Lodder-merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmia | Enrichment | GNB5 | 1.48 |
| 587 | Parkinson disease 14, autosomal recessive | Enrichment | PLA2G6 | 1.48 |
| 588 | Coronary artery disease, autosomal dominant, 1 | Enrichment | MEF2A | 1.48 |
| 589 | Lymphoproliferative syndrome 1 | Enrichment | ITK | 1.48 |
| 590 | Neurodegeneration with brain iron accumulation 2b | Enrichment | PLA2G6 | 1.48 |
| 591 | Night blindness, congenital stationary, autosomal dominant 3 | Enrichment | GNAT1 | 1.48 |
| 592 | Cytosolic phospholipase-a2 alpha deficiency associated bleeding disorder | Enrichment | PLA2G4A | 1.48 |
| 593 | Dystonia 25 | Enrichment | GNAL | 1.48 |
| 594 | Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies | Enrichment | RAP1B | 1.48 |
| 595 | Night blindness, congenital stationary, type 1g | Enrichment | GNAT1 | 1.48 |
| 596 | Long qt syndrome 16 | Enrichment | CALM3 | 1.48 |
| 597 | Hypocalcemia, autosomal dominant 2 | Enrichment | GNA11 | 1.48 |
| 598 | Charcot-marie-tooth disease, dominant intermediate f | Enrichment | GNB4 | 1.48 |
| 599 | Disorders of gnas inactivation | Enrichment | GNAS | 1.48 |
| 600 | Brain small vessel disease 5 with osteoporosis | Enrichment | ARHGEF15 | 1.48 |
| 601 | Platelet-activating factor acetylhydrolase deficiency | Enrichment | PLA2G7 | 1.48 |
| 602 | Autoimmune disease, multisystem, infantile-onset, 2 | Enrichment | ZAP70 | 1.48 |
| 603 | Immunodeficiency 22 | Enrichment | LCK | 1.48 |
| 604 | Thrombocytopenia 6 | Enrichment | SRC | 1.48 |
| 605 | Gastrointestinal ulceration, recurrent, with dysfunctional platelets | Enrichment | PLA2G4A | 1.48 |
| 606 | Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies | Enrichment | RHOA | 1.48 |
| 607 | Intellectual developmental disorder, autosomal dominant 42 | Enrichment | GNB1 | 1.48 |
| 608 | Holoprosencephaly 14 | Enrichment | PLCH1 | 1.48 |
| 609 | Noonan syndrome-like disorder with loose anagen hair 2 | Enrichment | PPP1CB | 1.48 |
| 610 | Sick sinus syndrome 4 | Enrichment | GNB2 | 1.48 |
| 611 | Autoinflammatory disease, systemic, with vasculitis | Enrichment | LYN | 1.48 |
| 612 | Menke-hennekam syndrome 1 | Enrichment | CREBBP | 1.48 |
| 613 | Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies | Enrichment | RHOA | 1.48 |
| 614 | Immunodeficiency 129 | Enrichment | RHOH | 1.48 |
| 615 | Auriculocondylar syndrome 2b | Enrichment | PLCB4 | 1.48 |
| 616 | Immunodeficiency 19, severe combined | Enrichment | CD3D | 1.48 |
| 617 | Long qt syndrome 15 | Enrichment | CALM2 | 1.48 |
| 618 | Rubinstein-taybi syndrome due to 16p13.3 microdeletion | Enrichment | CREBBP | 1.48 |
| 619 | Symptomatic form of coffin-lowry syndrome in female carriers | Enrichment | RPS6KA3 | 1.48 |
| 620 | T-cell immunodeficiency with epidermodysplasia verruciformis | Enrichment | RHOH | 1.48 |
| 621 | Immunodeficiency 133 with ectodermal dysplasia with or without peripheral neuropathy | Enrichment | ITPR3 | 1.48 |
| 622 | Colitis | Enrichment | SYK | 1.48 |
| 623 | 5q14.3 microdeletion syndrome | Enrichment | MEF2C | 1.48 |
| 624 | Complete atrioventricular septal defect without ventricular hypoplasia | Enrichment | MEF2C | 1.48 |
| 625 | Agammaglobulinemia 3 | Enrichment | CD79A | 1.48 |
| 626 | Immunodeficiency 19 | Enrichment | CD3D | 1.48 |
| 627 | Menke-hennekam syndrome | Enrichment | CREBBP | 1.48 |
| 628 | Cryptogenic multifocal ulcerous stenosing enteritis | Enrichment | PLA2G4A | 1.48 |
| 629 | Monostotic fibrous dysplasia | Enrichment | GNAS | 1.48 |
| 630 | Gnao1-related disorder | Enrichment | GNAO1 | 1.48 |
| 631 | Mef2c-related disorder | Enrichment | MEF2C | 1.48 |
| 632 | Phakomatosis cesiomarmorata | Enrichment | GNA11 | 1.48 |
| 633 | Kaposiform hemangioendothelioma | Enrichment | GNA14 | 1.48 |
| 634 | Mazabraud syndrome | Enrichment | GNAS | 1.48 |
| 635 | Familial benign flecked retina | Enrichment | PLA2G5 | 1.48 |
| 636 | Inflammatory bowel disease-recurrent sinopulmonary infections syndrome | Enrichment | NFAT5 | 1.48 |
| 637 | Zap70-related severe combined immunodeficiency | Enrichment | ZAP70 | 1.48 |
| 638 | Cornelia de lange syndrome 1 | Enrichment | HDAC8, SMC3 | 1.48 |
| 639 | Cornelia de lange syndrome | Enrichment | HDAC8, SMC3 | 1.48 |
| 640 | Systemic lupus erythematosus | Enrichment | FCGR2A, FCGR2B, ITGAM, SPP1 | 1.42 |
| 641 | Cerebral palsy | Enrichment | COL4A1, COL4A2, GNB1, PDGFRB | 1.42 |
| 642 | Breast cancer | Enrichment | AKT1, IL2, KRAS, PTEN, TP53 | 1.42 |
| 643 | Osteogenesis imperfecta, type iv | Enrichment | COL1A1, COL1A2 | 1.40 |
| 644 | Chromosome 1p36 deletion syndrome | Enrichment | HSPG2, PRKCZ | 1.40 |
| 645 | Chronic kidney disease | Enrichment | COL4A4, COL4A5 | 1.40 |
| 646 | Aortic aneurysm, familial thoracic 1 | Enrichment | COL3A1, FBN1 | 1.34 |
| 647 | Cataract | Enrichment | COL18A1, COL5A1 | 1.34 |
| 648 | Cleft lip/palate | Enrichment | BMP4, PDGFRA | 1.34 |
| 649 | Hereditary breast ovarian cancer syndrome | Enrichment | BCAR1, KRAS, PTEN, TP53 | 1.33 |
| 650 | Dilated cardiomyopathy | Enrichment | ACTA1, BRAF, FBN1, LAMA2, RAF1 | 1.32 |
| 651 | Specific learning disability | Enrichment | MAPK1, RPS6KA3 | 1.31 |
| 652 | Cri-du-chat syndrome | Enrichment | SEMA5A | 1.31 |
| 653 | Ehlers-danlos syndrome, vascular type | Enrichment | COL3A1 | 1.31 |
| 654 | Epiphyseal dysplasia, multiple, 1 | Enrichment | COL1A1 | 1.31 |
| 655 | Lymphatic malformation 1 | Enrichment | FLT4 | 1.31 |
| 656 | Amelogenesis imperfecta, type ib | Enrichment | COL17A1 | 1.31 |
| 657 | Leukocyte adhesion deficiency, type i | Enrichment | ITGB2 | 1.31 |
| 658 | Cutis laxa, autosomal dominant 1 | Enrichment | ELN | 1.31 |
| 659 | Ehlers-danlos syndrome, hypermobility type | Enrichment | COL3A1 | 1.31 |
| 660 | Sorsby fundus dystrophy | Enrichment | TIMP3 | 1.31 |
| 661 | Wagner vitreoretinopathy | Enrichment | VCAN | 1.31 |
| 662 | Myeloproliferative disorder, chronic, with eosinophilia | Enrichment | PDGFRB | 1.31 |
| 663 | Fibromatosis, gingival, 1 | Enrichment | SOS1 | 1.31 |
| 664 | Metaphyseal chondrodysplasia, schmid type | Enrichment | COL10A1 | 1.31 |
| 665 | Adrenocortical carcinoma, hereditary | Enrichment | TP53 | 1.31 |
| 666 | Camurati-engelmann disease 1 | Enrichment | TGFB1 | 1.31 |
| 667 | Costello syndrome | Enrichment | HRAS | 1.31 |
| 668 | Insensitivity to pain, congenital, with anhidrosis | Enrichment | NTRK1 | 1.31 |
| 669 | Manitoba oculotrichoanal syndrome | Enrichment | FREM1 | 1.31 |
| 670 | Trichomegaly | Enrichment | FGF5 | 1.31 |
| 671 | Epidermolysis bullosa, junctional 2c, laryngoonychocutaneous | Enrichment | LAMA3 | 1.31 |
| 672 | Bruck syndrome 1 | Enrichment | COL1A2 | 1.31 |
| 673 | Stiff skin syndrome | Enrichment | FBN1 | 1.31 |
| 674 | Intracranial hypertension, idiopathic | Enrichment | FLT4 | 1.31 |
| 675 | Camptodactyly-arthropathy-coxa vara-pericarditis syndrome | Enrichment | PRG4 | 1.31 |
| 676 | Kyphomelic dysplasia | Enrichment | CCN2 | 1.31 |
| 677 | Omodysplasia 1 | Enrichment | GPC6 | 1.31 |
| 678 | Myasthenic syndrome, congenital, 5 | Enrichment | LAMB2 | 1.31 |
| 679 | Pulmonary hypoplasia, primary | Enrichment | FGF10 | 1.31 |
| 680 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | Enrichment | PIK3R5 | 1.31 |
| 681 | Immunodeficiency 41 with lymphoproliferation and autoimmunity | Enrichment | IL2RA | 1.31 |
| 682 | Bifid nose with or without anorectal and renal anomalies | Enrichment | FREM1 | 1.31 |
| 683 | Loeys-dietz syndrome 2 | Enrichment | TGFBR1 | 1.31 |
| 684 | Parkinson disease 8, autosomal dominant | Enrichment | GDF6 | 1.31 |
| 685 | Aortic aneurysm, familial thoracic 2 | Enrichment | ACTA2 | 1.31 |
| 686 | Doyne honeycomb retinal dystrophy | Enrichment | EFEMP1 | 1.31 |
| 687 | Piebald trait | Enrichment | KIT | 1.31 |
| 688 | Aural atresia, congenital | Enrichment | FGFR2 | 1.31 |
| 689 | Legg-calve-perthes disease | Enrichment | COL2A1 | 1.31 |
| 690 | Deafness, autosomal dominant 20 | Enrichment | ACTG1 | 1.31 |
| 691 | Keratosis, seborrheic | Enrichment | FGFR3 | 1.31 |
| 692 | Multiple synostoses syndrome 2 | Enrichment | GDF5 | 1.31 |
| 693 | Smooth muscle dysfunction syndrome | Enrichment | ACTA2 | 1.31 |
| 694 | Leukocyte adhesion deficiency, type iii | Enrichment | ITGB2 | 1.31 |
| 695 | Lissencephaly 1 | Enrichment | LAMB1 | 1.31 |
| 696 | Myopathy, mitochondrial progressive, with congenital cataract and developmental delay | Enrichment | GFER | 1.31 |
| 697 | Cutis laxa, autosomal recessive, type ic | Enrichment | LTBP4 | 1.31 |
| 698 | Aortic aneurysm, familial thoracic 6 | Enrichment | ACTA2 | 1.31 |
| 699 | Epithelial recurrent erosion dystrophy | Enrichment | COL17A1 | 1.31 |
| 700 | Baraitser-winter syndrome 2 | Enrichment | ACTG1 | 1.31 |
| 701 | Specific language impairment 5 | Enrichment | COL4A4 | 1.31 |
| 702 | Silver-russell syndrome 3 | Enrichment | IGF2 | 1.31 |
| 703 | Osteogenesis imperfecta, type xiii | Enrichment | BMP1 | 1.31 |
| 704 | Beaulieu-boycott-innes syndrome | Enrichment | FBN1 | 1.31 |
| 705 | Moyamoya disease 5 | Enrichment | ACTA2 | 1.31 |
| 706 | Pierson syndrome | Enrichment | LAMB2 | 1.31 |
| 707 | Lymphoma, hodgkin, classic | Enrichment | TP53 | 1.31 |
| 708 | Schwartz-jampel syndrome, type 1 | Enrichment | HSPG2 | 1.31 |
| 709 | Brachydactyly, type a1, c | Enrichment | GDF5 | 1.31 |
| 710 | Symphalangism, proximal, 1b | Enrichment | GDF5 | 1.31 |
| 711 | Supravalvular aortic stenosis | Enrichment | ELN | 1.31 |
| 712 | Pain sensitivity quantitative trait locus 1 | Enrichment | NTRK1 | 1.31 |
| 713 | Antley-bixler syndrome without genital anomalies or disordered steroidogenesis | Enrichment | FGFR2 | 1.31 |
| 714 | Spondyloepimetaphyseal dysplasia, li-shao-li type | Enrichment | CCN2 | 1.31 |
| 715 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 | Enrichment | COL4A2 | 1.31 |
| 716 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 1 | Enrichment | COL1A1 | 1.31 |
| 717 | Epidermolysis bullosa, junctional 3b, severe | Enrichment | LAMC2 | 1.31 |
| 718 | Epidermolysis bullosa, junctional 3a, intermediate | Enrichment | LAMC2 | 1.31 |
| 719 | Epidermolysis bullosa, junctional 4, intermediate | Enrichment | COL17A1 | 1.31 |
| 720 | Waardenburg syndrome, type 2f | Enrichment | KITLG | 1.31 |
| 721 | Stickler syndrome, type vi | Enrichment | COL9A3 | 1.31 |
| 722 | Fibromuscular dysplasia, multifocal | Enrichment | COL5A1 | 1.31 |
| 723 | Intellectual developmental disorder, autosomal dominant 48 | Enrichment | RAC1 | 1.31 |
| 724 | Epidermolysis bullosa, junctional 2a, intermediate | Enrichment | LAMA3 | 1.31 |
| 725 | Epidermolysis bullosa, junctional 5a, intermediate | Enrichment | ITGB4 | 1.31 |
| 726 | Birk-aharoni syndrome | Enrichment | PSMC1 | 1.31 |
| 727 | Noonan syndrome 12 | Enrichment | RRAS2 | 1.31 |
| 728 | Cebalid syndrome | Enrichment | MTOR | 1.31 |
| 729 | Polymicrogyria with or without vascular-type ehlers-danlos syndrome | Enrichment | COL3A1 | 1.31 |
| 730 | Inflammatory bowel disease, immunodeficiency, and encephalopathy | Enrichment | TGFB1 | 1.31 |
| 731 | Kowarski syndrome | Enrichment | GH1 | 1.31 |
| 732 | Infantile myofibromatosis | Enrichment | PDGFRB | 1.31 |
| 733 | Proteasome-associated autoinflammatory syndrome 3 | Enrichment | PSMB4 | 1.31 |
| 734 | Nephrotic syndrome, type 5, with or without ocular abnormalities | Enrichment | LAMB2 | 1.31 |
| 735 | Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome | Enrichment | ITGA3 | 1.31 |
| 736 | Childhood hepatocellular carcinoma | Enrichment | MET | 1.31 |
| 737 | Recessive dystrophic epidermolysis bullosa | Enrichment | COL7A1 | 1.31 |
| 738 | Marfanoid-progeroid-lipodystrophy syndrome | Enrichment | FBN1 | 1.31 |
| 739 | Senior-loken syndrome 7 | Enrichment | AKT3 | 1.31 |
| 740 | Split hand-foot malformation | Enrichment | FGFR2 | 1.31 |
| 741 | Rosette-forming glioneuronal tumor | Enrichment | FGFR1 | 1.31 |
| 742 | Optic disk drusen | Enrichment | EFEMP1 | 1.31 |
| 743 | Papillary renal cell carcinoma | Enrichment | MET | 1.31 |
| 744 | Congenital mesoblastic nephroma | Enrichment | NTRK3 | 1.31 |
| 745 | Camurati-engelmann disease | Enrichment | TGFB1 | 1.31 |
| 746 | Congenital fibrosarcoma | Enrichment | TP53 | 1.31 |
| 747 | Glomerulonephritis | Enrichment | COL4A4 | 1.31 |
| 748 | Li-fraumeni syndrome 1 | Enrichment | TP53 | 1.31 |
| 749 | Sarcoma | Enrichment | TP53 | 1.31 |
| 750 | Microphthalmia/coloboma 6 | Enrichment | GDF6 | 1.31 |
| 751 | Glaucoma, primary closed-angle | Enrichment | COL18A1 | 1.31 |
| 752 | Trigonocephaly 2 | Enrichment | FREM1 | 1.31 |
| 753 | Steel syndrome | Enrichment | COL27A1 | 1.31 |
| 754 | Familial avascular necrosis of the femoral head | Enrichment | COL2A1 | 1.31 |
| 755 | Immune system disease | Enrichment | CDC42 | 1.31 |
| 756 | Hodgkin's lymphoma | Enrichment | TP53 | 1.31 |
| 757 | Fibrosarcoma | Enrichment | NTRK3 | 1.31 |
| 758 | Bardet-biedl syndrome 16 | Enrichment | AKT3 | 1.31 |
| 759 | Epidermolysis bullosa, junctional 2b, severe | Enrichment | LAMA3 | 1.31 |
| 760 | Cataract 16, multiple types | Enrichment | COL12A1 | 1.31 |
| 761 | Proximal symphalangism | Enrichment | GDF5 | 1.31 |
| 762 | Smith-kingsmore syndrome | Enrichment | MTOR | 1.31 |
| 763 | Hereditary lymphedema i | Enrichment | FLT4 | 1.31 |
| 764 | Craniosynostosis 7 | Enrichment | BMP2 | 1.31 |
| 765 | Congenital amegakaryocytic thrombocytopenia | Enrichment | THPO | 1.31 |
| 766 | Short stature due to growth hormone qualitative anomaly | Enrichment | GH1 | 1.31 |
| 767 | Wagner disease | Enrichment | VCAN | 1.31 |
| 768 | Autosomal dominant nonsyndromic deafness | Enrichment | FGFR2 | 1.31 |
| 769 | Chronic eosinophilic leukemia | Enrichment | PDGFRA | 1.31 |
| 770 | Vacterl with hydrocephalus | Enrichment | PTEN | 1.31 |
| 771 | Growth delay due to insulin-like growth factor type 1 deficiency | Enrichment | IGF1 | 1.31 |
| 772 | Dentinogenesis imperfecta | Enrichment | COL1A2 | 1.31 |
| 773 | Epidermolysis bullosa dystrophica | Enrichment | COL7A1 | 1.31 |
| 774 | B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality | Enrichment | PDGFRA | 1.31 |
| 775 | B-lymphoblastic leukemia/lymphoma with t | Enrichment | KIT | 1.31 |
| 776 | Juvenile polyposis of infancy | Enrichment | PTEN | 1.31 |
| 777 | Lens subluxation | Enrichment | FBN1 | 1.31 |
| 778 | Silver-russell syndrome due to an imprinting defect of 11p15 | Enrichment | IGF2 | 1.31 |
| 779 | Pleomorphic rhabdomyosarcoma | Enrichment | TP53 | 1.31 |
| 780 | Tafro syndrome | Enrichment | MAP2K2 | 1.31 |
| 781 | Intestinal obstruction | Enrichment | ACTG2 | 1.31 |
| 782 | Wooly hair nevus | Enrichment | HRAS | 1.31 |
| 783 | Silver-russell syndrome due to 11p15 microduplication | Enrichment | IGF2 | 1.31 |
| 784 | Renal cell carcinoma, nonpapillary | Enrichment | MET, MTOR | 1.28 |
| 785 | Wilms tumor 1 | Enrichment | BRAF, IGF2 | 1.28 |
| 786 | Congenital myopathy 4a, autosomal dominant | Enrichment | ACTA1, ITGA7 | 1.28 |
| 787 | Hydrocephalus | Enrichment | FGFR2, PDGFRB | 1.28 |
| 788 | Primary ovarian insufficiency | Enrichment | BMP6, IGF2R, KDR, NTRK1 | 1.24 |
| 789 | Hypertension | Enrichment | COL4A4, COL4A5 | 1.23 |
| 790 | Spinocerebellar ataxia 29 | Enrichment | ITPR1 | 1.19 |
| 791 | Pseudohypoparathyroidism, type ia | Enrichment | GNAS | 1.19 |
| 792 | Pituitary adenoma 4, acth-secreting | Enrichment | GNAI2 | 1.19 |
| 793 | Cutis marmorata telangiectatica congenita | Enrichment | GNA11 | 1.19 |
| 794 | Thumb deformity | Enrichment | CREBBP | 1.19 |
| 795 | Isolated growth hormone deficiency, type iii, with agammaglobulinemia | Enrichment | BTK | 1.19 |
| 796 | Histiocytoma, angiomatoid fibrous | Enrichment | CREB1 | 1.19 |
| 797 | Pigmented nodular adrenocortical disease, primary, 1 | Enrichment | GNAS | 1.19 |
| 798 | Pseudopseudohypoparathyroidism | Enrichment | GNAS | 1.19 |
| 799 | Agammaglobulinemia 4, autosomal recessive | Enrichment | BLNK | 1.19 |
| 800 | Agammaglobulinemia 6, autosomal recessive | Enrichment | CD79B | 1.19 |
| 801 | Charcot-marie-tooth disease, demyelinating, type 4f | Enrichment | PLD3 | 1.19 |
| 802 | Ventricular tachycardia, catecholaminergic polymorphic, 4 | Enrichment | CALM1 | 1.19 |
| 803 | Lethal congenital contracture syndrome 8 | Enrichment | ADCY6 | 1.19 |
| 804 | Night blindness, congenital stationary, type 1h | Enrichment | GNB3 | 1.19 |
| 805 | Immunodeficiency, common variable, 12, with autoimmunity | Enrichment | NFKB1 | 1.19 |
| 806 | Syndactyly, type iii | Enrichment | HDAC8 | 1.19 |
| 807 | Long qt syndrome 14 | Enrichment | CALM1 | 1.19 |
| 808 | Genitourinary and/or brain malformation syndrome | Enrichment | PPP1R12A | 1.19 |
| 809 | Agammaglobulinemia, x-linked | Enrichment | BTK | 1.19 |
| 810 | Menke-hennekam syndrome 2 | Enrichment | EP300 | 1.19 |
| 811 | Spinocerebellar ataxia 46 | Enrichment | PLD3 | 1.19 |
| 812 | Wilson-turner syndrome | Enrichment | HDAC8 | 1.19 |
| 813 | Noonan syndrome-like disorder with loose anagen hair | Enrichment | PPP1CB | 1.19 |
| 814 | Lymphoproliferative syndrome | Enrichment | ITK | 1.19 |
| 815 | Acute myeloid leukemia with kat6a-crebbp fusion | Enrichment | CREBBP | 1.19 |
| 816 | Agammaglobulinemia 4 | Enrichment | BLNK | 1.19 |
| 817 | Agammaglobulinemia 6 | Enrichment | CD79B | 1.19 |
| 818 | Autosomal dominant hypocalcemia | Enrichment | GNA11 | 1.19 |
| 819 | Pseudohypoparathyroidism | Enrichment | GNAS | 1.19 |
| 820 | Body mass index quantitative trait locus 19 | Enrichment | ADCY3 | 1.19 |
| 821 | Ocular melanoma | Enrichment | PLCB4 | 1.19 |
| 822 | Immunodeficiency 17 | Enrichment | CD3G | 1.19 |
| 823 | Hypopituitarism | Enrichment | GNAI2 | 1.19 |
| 824 | Lodder-merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmia | Enrichment | GNB5 | 1.19 |
| 825 | Immunodeficiency 52 | Enrichment | LAT | 1.19 |
| 826 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 4 | Enrichment | MYL9 | 1.19 |
| 827 | Joint contractures, osteochondromas, and b-cell lymphoma | Enrichment | NFATC2 | 1.19 |
| 828 | Charcot-marie-tooth disease type 4f | Enrichment | PLD3 | 1.19 |
| 829 | Arthritis | Enrichment | SYK | 1.19 |
| 830 | Acth-independent macronodular adrenal hyperplasia | Enrichment | GNAS | 1.19 |
| 831 | Common variable immunodeficiency 12 | Enrichment | NFKB1 | 1.19 |
| 832 | Infantile osteopetrosis with neuroaxonal dysplasia | Enrichment | PLA2G6 | 1.19 |
| 833 | Cerebral visual impairment | Enrichment | GNB1 | 1.19 |
| 834 | Phakomatosis cesioflammea | Enrichment | GNA11 | 1.19 |
| 835 | Dandy-walker syndrome | Enrichment | BRAF, PDGFRB | 1.19 |
| 836 | Thrombocytopenia | Enrichment | ITGA2B, ITGB3, SRC, THPO | 1.14 |
| 837 | Brachydactyly, type a1 | Enrichment | GDF5 | 1.14 |
| 838 | Hyper-ige syndrome 1, autosomal dominant, with recurrent infections | Enrichment | ITGB3 | 1.14 |
| 839 | Brachydactyly, type c | Enrichment | GDF5 | 1.14 |
| 840 | Retinal arteries, tortuosity of | Enrichment | COL4A1 | 1.14 |
| 841 | Hypogonadotropic hypogonadism 2 with or without anosmia | Enrichment | FGFR1 | 1.14 |
| 842 | Larsen syndrome | Enrichment | FGFR3 | 1.14 |
| 843 | Palmoplantar keratoderma, punctate type ia | Enrichment | COL14A1 | 1.14 |
| 844 | Klippel-feil syndrome 1, autosomal dominant | Enrichment | GDF6 | 1.14 |
| 845 | Thyroid carcinoma, familial medullary | Enrichment | NTRK1 | 1.14 |
| 846 | Ataxia-telangiectasia | Enrichment | BRAF | 1.14 |
| 847 | Spondyloepiphyseal dysplasia congenita | Enrichment | COL2A1 | 1.14 |
| 848 | Exfoliation syndrome | Enrichment | LTBP2 | 1.14 |
| 849 | Tumoral calcinosis, hyperphosphatemic, familial, 1 | Enrichment | FGF23 | 1.14 |
| 850 | Acromesomelic dysplasia 2a | Enrichment | GDF5 | 1.14 |
| 851 | Thrombocythemia 1 | Enrichment | THPO | 1.14 |
| 852 | Hypophosphatemic rickets, autosomal dominant | Enrichment | FGF23 | 1.14 |
| 853 | Acromesomelic dysplasia 2c | Enrichment | GDF5 | 1.14 |
| 854 | Megalocornea | Enrichment | COL11A1 | 1.14 |
| 855 | Acromesomelic dysplasia 2b | Enrichment | GDF5 | 1.14 |
| 856 | Dyssegmental dysplasia, silverman-handmaker type | Enrichment | HSPG2 | 1.14 |
| 857 | Proteasome-associated autoinflammatory syndrome 1 | Enrichment | PSMB4 | 1.14 |
| 858 | Nail disorder, nonsyndromic congenital, 4 | Enrichment | COL7A1 | 1.14 |
| 859 | Hypophosphatasia, infantile | Enrichment | COL11A2 | 1.14 |
| 860 | Glomerulopathy with fibronectin deposits 2 | Enrichment | FN1 | 1.14 |
| 861 | Nuchal bleb, familial | Enrichment | SOS1 | 1.14 |
| 862 | Muscular dystrophy, duchenne type | Enrichment | LTBP4 | 1.14 |
| 863 | Osteogenic sarcoma | Enrichment | TP53 | 1.14 |
| 864 | Transposition of the great arteries, dextro-looped | Enrichment | BMP2 | 1.14 |
| 865 | Muscular dystrophy, congenital merosin-deficient, 1a | Enrichment | LAMA2 | 1.14 |
| 866 | Nasopharyngeal carcinoma | Enrichment | TP53 | 1.14 |
| 867 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi | Enrichment | PIK3R1 | 1.14 |
| 868 | Caffey disease | Enrichment | COL1A1 | 1.14 |
| 869 | Muscular dystrophy, congenital, due to integrin alpha-7 deficiency | Enrichment | ITGA7 | 1.14 |
| 870 | Brain small vessel disease 2 | Enrichment | COL4A2 | 1.14 |
| 871 | Chromosome 8p11 myeloproliferative syndrome | Enrichment | FGFR1 | 1.14 |
| 872 | Ullrich congenital muscular dystrophy 2 | Enrichment | COL12A1 | 1.14 |
| 873 | Bethlem myopathy 2 | Enrichment | COL12A1 | 1.14 |
| 874 | Dyskeratosis congenita, autosomal dominant 6 | Enrichment | THPO | 1.14 |
| 875 | Neonatal nephrocutaneous inflammatory syndrome | Enrichment | EGFR | 1.14 |
| 876 | Immunodeficiency 14a with lymphoproliferation, autosomal dominant | Enrichment | PIK3R1 | 1.14 |
| 877 | Microangiopathy and leukoencephalopathy, pontine, autosomal dominant | Enrichment | COL4A1 | 1.14 |
| 878 | Epidermolysis bullosa, junctional 6, with pyloric atresia | Enrichment | ITGA6 | 1.14 |
| 879 | Pilarowski-bjornsson syndrome | Enrichment | COL4A3 | 1.14 |
| 880 | Alport syndrome 3b, autosomal recessive | Enrichment | COL4A3 | 1.14 |
| 881 | Tethered spinal cord syndrome | Enrichment | BRAF | 1.14 |
| 882 | Cutis laxa, autosomal recessive, type ib | Enrichment | EFEMP2 | 1.14 |
| 883 | Dedifferentiated liposarcoma | Enrichment | MDM2 | 1.14 |
| 884 | Poretti-boltshauser syndrome | Enrichment | LAMA1 | 1.14 |
| 885 | Proteosome-associated autoinflammatory syndrome | Enrichment | PSMB4 | 1.14 |
| 886 | Isolated ectopia lentis | Enrichment | FBN1 | 1.14 |
| 887 | Autosomal dominant cutis laxa | Enrichment | ELN | 1.14 |
| 888 | Isolated growth hormone deficiency, type ib | Enrichment | GH1 | 1.14 |
| 889 | Loeys-dietz syndrome 1 | Enrichment | TGFBR1 | 1.14 |
| 890 | Hamartoma | Enrichment | FGFR3 | 1.14 |
| 891 | Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps | Enrichment | COL4A1 | 1.14 |
| 892 | Atypical teratoid rhabdoid tumor | Enrichment | TP53 | 1.14 |
| 893 | Anaplastic astrocytoma | Enrichment | TP53 | 1.14 |
| 894 | Immunodeficiency 14 | Enrichment | PIK3R1 | 1.14 |
| 895 | Squamous cell carcinoma | Enrichment | TP53 | 1.14 |
| 896 | Adenocarcinoma | Enrichment | TP53 | 1.14 |
| 897 | Hematuria, benign familial, 2 | Enrichment | COL4A3 | 1.14 |
| 898 | Laryngeal squamous cell carcinoma | Enrichment | PTEN | 1.14 |
| 899 | Bone osteosarcoma | Enrichment | TP53 | 1.14 |
| 900 | Growth delay due to insulin-like growth factor i resistance | Enrichment | IGF1R | 1.14 |
| 901 | Bleeding disorder, platelet-type, 24 | Enrichment | ITGB3 | 1.14 |
| 902 | Neonatal inflammatory skin and bowel disease | Enrichment | EGFR | 1.14 |
| 903 | Well-differentiated liposarcoma | Enrichment | MDM2 | 1.14 |
| 904 | Alopecia - intellectual disability syndrome | Enrichment | ITGB6 | 1.14 |
| 905 | Renal cell carcinoma | Enrichment | MET | 1.14 |
| 906 | Multiple epiphyseal dysplasia | Enrichment | COL2A1 | 1.14 |
| 907 | Thyroid hemiagenesis | Enrichment | PSMD3 | 1.14 |
| 908 | Testicular cancer | Enrichment | FGFR3 | 1.14 |
| 909 | Isolated klippel-feil syndrome | Enrichment | GDF6 | 1.14 |
| 910 | Beckwith-wiedemann syndrome due to imprinting defect of 11p15 | Enrichment | IGF2 | 1.14 |
| 911 | Familial drusen | Enrichment | EFEMP1 | 1.14 |
| 912 | Hyperpigmentation of the skin | Enrichment | COL7A1 | 1.14 |
| 913 | Lama2-related muscular dystrophy | Enrichment | LAMA2 | 1.14 |
| 914 | Corpus callosum, agenesis of | Enrichment | COL4A1, CREBBP | 1.07 |
| 915 | Anterior segment dysgenesis | Enrichment | COL4A1, ITPR1 | 1.07 |
| 916 | Isolated corpus callosum agenesis | Enrichment | COL4A1, CREBBP | 1.07 |
| 917 | Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome | Enrichment | COL4A1, CREBBP | 1.07 |
| 918 | Craniosynostosis | Enrichment | FGFR2, FGFR3 | 1.06 |
| 919 | Endometrial cancer | Enrichment | FGFR2, PTEN | 1.03 |
| 920 | Gillespie syndrome | Enrichment | ITPR1 | 1.02 |
| 921 | Succinic semialdehyde dehydrogenase deficiency | Enrichment | GPLD1 | 1.02 |
| 922 | Agammaglobulinemia 1, autosomal recessive | Enrichment | BTK | 1.02 |
| 923 | Late-onset retinal degeneration | Enrichment | PLA2G5 | 1.02 |
| 924 | Nephrotic syndrome, type 3 | Enrichment | PLCE1 | 1.02 |
| 925 | Agammaglobulinemia 1 | Enrichment | BTK | 1.02 |
| 926 | Intraocular pressure quantitative trait locus | Enrichment | CREBBP | 1.02 |
| 927 | Cushing syndrome due to bilateral macronodular adrenocortical disease | Enrichment | GNAS | 1.02 |
| 928 | Melanoma of soft tissue | Enrichment | CREB1 | 1.02 |
| 929 | Hypomyelination neuropathy-arthrogryposis syndrome | Enrichment | ADCY6 | 1.02 |
| 930 | Kaposi sarcoma | Enrichment | IL6 | 1.02 |
| 931 | Retinitis pigmentosa 91 | Enrichment | IMPG1 | 1.02 |
| 932 | Amelogenesis imperfecta, type iiia | Enrichment | ITGB6 | 1.02 |
| 933 | Isolated growth hormone deficiency, type ii | Enrichment | GH1 | 1.02 |
| 934 | Diffuse gastric and lobular breast cancer syndrome | Enrichment | KRAS | 1.02 |
| 935 | Small cell cancer of the lung | Enrichment | TP53 | 1.02 |
| 936 | Nemaline myopathy 2 | Enrichment | ACTA1 | 1.02 |
| 937 | Phenylketonuria | Enrichment | COL1A1 | 1.02 |
| 938 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 | Enrichment | ACTG2 | 1.02 |
| 939 | Schizencephaly | Enrichment | COL4A1 | 1.02 |
| 940 | Autoimmune lymphoproliferative syndrome | Enrichment | ACTA2 | 1.02 |
| 941 | Microtia-anotia | Enrichment | BMP5 | 1.02 |
| 942 | Neurofibromatosis-noonan syndrome | Enrichment | MAP2K2 | 1.02 |
| 943 | Glaucoma 3, primary infantile, b | Enrichment | LTBP2 | 1.02 |
| 944 | Chromosome 22q11.2 deletion syndrome, distal | Enrichment | MAPK1 | 1.02 |
| 945 | Epidermolysis bullosa simplex 5c, with pyloric atresia | Enrichment | ITGB4 | 1.02 |
| 946 | Focal cortical dysplasia, type ii | Enrichment | MTOR | 1.02 |
| 947 | Retinitis pigmentosa 26 | Enrichment | ITGA4 | 1.02 |
| 948 | Aminoacylase 1 deficiency | Enrichment | ACTB | 1.02 |
| 949 | Arthrogryposis multiplex congenita 2, neurogenic type | Enrichment | COL25A1 | 1.02 |
| 950 | Hereditary ataxia | Enrichment | PRKCG | 1.02 |
| 951 | Embryonal rhabdomyosarcoma | Enrichment | TP53 | 1.02 |
| 952 | Craniopharyngioma | Enrichment | BRAF | 1.02 |
| 953 | Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia | Enrichment | CDC42 | 1.02 |
| 954 | Pilocytic astrocytoma | Enrichment | KRAS | 1.02 |
| 955 | Corneal dystrophy | Enrichment | COL17A1 | 1.02 |
| 956 | Newborn respiratory distress syndrome | Enrichment | BRAF | 1.02 |
| 957 | Epidermolytic nevus | Enrichment | HRAS | 1.02 |
| 958 | Epidermolytic hyperkeratosis | Enrichment | COL7A1 | 1.02 |
| 959 | Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) | Enrichment | KIT | 1.02 |
| 960 | Knobloch syndrome | Enrichment | COL18A1 | 1.02 |
| 961 | Silver-russell syndrome due to a point mutation | Enrichment | IGF2 | 1.02 |
| 962 | Mitral valve insufficiency | Enrichment | FBN1 | 1.02 |
| 963 | Non-syndromic bicoronal craniosynostosis | Enrichment | FGFR3 | 1.02 |
| 964 | Pediatric systemic lupus erythematosus | Enrichment | SPP1 | 1.02 |
| 965 | Systemic mastocytosis with associated hematologic neoplasm | Enrichment | KIT | 1.02 |
| 966 | Intermediate nemaline myopathy | Enrichment | ACTA1 | 1.02 |
| 967 | Systemic-onset juvenile idiopathic arthritis | Enrichment | IL6 | 1.02 |
| 968 | Isolated focal cortical dysplasia type ii | Enrichment | MTOR | 1.02 |
| 969 | Rare x-linked non-syndromic sensorineural deafness type dfn | Enrichment | COL4A6 | 1.02 |
| 970 | Gingival fibromatosis | Enrichment | SOS1 | 1.02 |
| 971 | Male infertility due to gonadal dysgenesis or sperm disorder | Enrichment | SOS2 | 1.02 |
| 972 | Pseudomyogenic hemangioendothelioma | Enrichment | ACTB | 1.02 |
| 973 | Genetic steroid-resistant nephrotic syndrome | Enrichment | COL4A3, LAMA5, PLCE1 | 1.00 |
| 974 | Myocardial infarction | Enrichment | ITGB3, PSMA6 | 0.99 |
| 975 | Tooth agenesis | Enrichment | FGFR1, TGFA | 0.99 |
| 976 | Cleft palate, isolated | Enrichment | COL11A1, GNB1 | 0.98 |
| 977 | Hereditary retinal dystrophy | Enrichment | COL11A2, COL18A1, COL2A1, COL9A1, EFEMP1, IMPG1, IMPG2, ITGA4, LAMA1, TIMP3, VCAN | 0.97 |
| 978 | Fundus dystrophy | Enrichment | COL11A2, COL18A1, COL2A1, COL9A1, EFEMP1, IMPG1, IMPG2, ITGA4, LAMA1, TIMP3, VCAN | 0.97 |
| 979 | Inherited cancer-predisposing syndrome | Enrichment | EGFR, KIT, MET, PDGFRA, PTEN, TP53 | 0.96 |
| 980 | Sensorineural hearing loss | Enrichment | COL11A2, COL9A1, HGF | 0.94 |
| 981 | Polycystic kidney disease | Enrichment | COL4A4, HDAC8 | 0.93 |
| 982 | Polycystic liver disease 1 with or without kidney cysts | Enrichment | FBN1 | 0.93 |
| 983 | Epidermolytic hyperkeratosis 1 | Enrichment | COL7A1 | 0.93 |
| 984 | Arrhythmogenic right ventricular dysplasia, familial, 1 | Enrichment | TGFB3 | 0.93 |
| 985 | Visceral myopathy 1 | Enrichment | ACTG2 | 0.93 |
| 986 | Epidermolysis bullosa simplex 1c, localized | Enrichment | ITGB4 | 0.93 |
| 987 | Arthrogryposis, renal dysfunction, and cholestasis 1 | Enrichment | FBN1 | 0.93 |
| 988 | Congenital myopathy 3 with rigid spine | Enrichment | ACTA1 | 0.93 |
| 989 | Rhabdomyosarcoma 2 | Enrichment | TP53 | 0.93 |
| 990 | Macrocephaly/autism syndrome | Enrichment | PTEN | 0.93 |
| 991 | Rheumatoid arthritis, systemic juvenile | Enrichment | IL6 | 0.93 |
| 992 | Atrioventricular septal defect | Enrichment | BMP5 | 0.93 |
| 993 | Knobloch syndrome 1 | Enrichment | COL18A1 | 0.93 |
| 994 | Goldberg-shprintzen syndrome | Enrichment | FBN1 | 0.93 |
| 995 | Congenital heart defects, multiple types, 4 | Enrichment | BMP7 | 0.93 |
| 996 | Glanzmann thrombasthenia 2 | Enrichment | ITGB3 | 0.93 |
| 997 | Muscular dystrophy, limb-girdle, autosomal recessive 23 | Enrichment | LAMA2 | 0.93 |
| 998 | Pre-eclampsia | Enrichment | FLT1 | 0.93 |
| 999 | Fuchs' endothelial dystrophy | Enrichment | COL8A2 | 0.93 |
| 1000 | Lymphoma | Enrichment | TP53 | 0.93 |
| 1001 | Congenital ptosis | Enrichment | COL25A1 | 0.93 |
| 1002 | Acute myeloid leukemia with maturation | Enrichment | KIT | 0.93 |
| 1003 | Polycystic liver disease 1 | Enrichment | FBN1 | 0.93 |
| 1004 | Night blindness | Enrichment | EFEMP1 | 0.93 |
| 1005 | Hemangioma | Enrichment | PTEN | 0.93 |
| 1006 | Arrhythmogenic right ventricular dysplasia 1 | Enrichment | TGFB3 | 0.93 |
| 1007 | Aplasia cutis congenita | Enrichment | ITGB4 | 0.93 |
| 1008 | Coloboma of choroid and retina | Enrichment | ACTG1 | 0.93 |
| 1009 | Acute myeloid leukemia with t(8;21)(q22;q22) translocation | Enrichment | KIT | 0.93 |
| 1010 | Diffuse cutaneous systemic sclerosis | Enrichment | CCN2 | 0.93 |
| 1011 | Severe congenital nemaline myopathy | Enrichment | ACTA1 | 0.93 |
| 1012 | Chorea, benign hereditary | Enrichment | ADCY5 | 0.90 |
| 1013 | Spastic paraplegia 17, autosomal dominant | Enrichment | GNG3 | 0.90 |
| 1014 | Pseudohypoparathyroidism, type ib | Enrichment | GNAS | 0.90 |
| 1015 | Lipodystrophy, congenital generalized, type 2 | Enrichment | GNG3 | 0.90 |
| 1016 | Spinocerebellar ataxia 15 | Enrichment | ITPR1 | 0.90 |
| 1017 | Developmental and epileptic encephalopathy 12 | Enrichment | PLCB1 | 0.90 |
| 1018 | Familial sick sinus syndrome | Enrichment | GNB2 | 0.90 |
| 1019 | Pancreatic cancer | Enrichment | KRAS, TP53 | 0.90 |
| 1020 | Tetralogy of fallot | Enrichment | FLT4, KDR | 0.87 |
| 1021 | Spondyloepiphyseal dysplasia with congenital joint dislocations | Enrichment | ACAN | 0.85 |
| 1022 | Glaucoma, primary open angle | Enrichment | LTBP2 | 0.85 |
| 1023 | Corneal dystrophy, posterior polymorphous, 1 | Enrichment | COL8A2 | 0.85 |
| 1024 | Split-hand/foot malformation 1 | Enrichment | FGFR2 | 0.85 |
| 1025 | Wilms tumor, aniridia, genitourinary anomalies, and impaired intellectual development syndrome | Enrichment | BDNF | 0.85 |
| 1026 | Moyamoya disease 1 | Enrichment | ACTA2 | 0.85 |
| 1027 | Type 1 diabetes mellitus | Enrichment | IL6 | 0.85 |
| 1028 | Wilms tumor 5 | Enrichment | BRAF | 0.85 |
| 1029 | Dental anomalies and short stature | Enrichment | LTBP3 | 0.85 |
| 1030 | Wiedemann-steiner syndrome | Enrichment | SMC3 | 0.85 |
| 1031 | Mitochondrial dna depletion syndrome 1 | Enrichment | TYMP | 0.85 |
| 1032 | Inflammatory bowel disease 25, autosomal recessive | Enrichment | TGFB1 | 0.85 |
| 1033 | Intestinal pseudo-obstruction | Enrichment | ACTG2 | 0.85 |
| 1034 | Congenital fibrosis of the extraocular muscles | Enrichment | COL25A1 | 0.85 |
| 1035 | Pain disorder | Enrichment | COL5A1 | 0.85 |
| 1036 | Patent ductus arteriosus | Enrichment | PSMC3 | 0.85 |
| 1037 | Adrenocortical carcinoma | Enrichment | TP53 | 0.85 |
| 1038 | Limited scleroderma | Enrichment | CCN2 | 0.85 |
| 1039 | Il10-related early-onset inflammatory bowel disease | Enrichment | TGFB1 | 0.85 |
| 1040 | 46,xy disorder of sex development | Enrichment | FGFR3 | 0.85 |
| 1041 | Typical nemaline myopathy | Enrichment | ACTA1 | 0.85 |
| 1042 | Charcot-marie-tooth disease | Enrichment | ARHGEF10, LAMA2, PLD3 | 0.82 |
| 1043 | Capillary malformations, congenital | Enrichment | GNA11 | 0.81 |
| 1044 | Night blindness, congenital stationary, type 1c | Enrichment | GNAT1 | 0.81 |
| 1045 | Rubinstein-taybi syndrome 2 | Enrichment | EP300 | 0.81 |
| 1046 | Prostate cancer | Enrichment | PTEN, TP53 | 0.79 |
| 1047 | Esophageal cancer | Enrichment | TP53 | 0.79 |
| 1048 | Glaucoma 3, primary congenital, a | Enrichment | LTBP2 | 0.79 |
| 1049 | Silver-russell syndrome 1 | Enrichment | IGF2 | 0.79 |
| 1050 | Brugada syndrome 1 | Enrichment | FBN1 | 0.79 |
| 1051 | Waardenburg syndrome, type 2e | Enrichment | KITLG | 0.79 |
| 1052 | Multiple enchondromatosis, maffucci type | Enrichment | COL2A1 | 0.79 |
| 1053 | Hereditary hemorrhagic telangiectasia | Enrichment | GDF2 | 0.79 |
| 1054 | Megacolon | Enrichment | AKT3 | 0.79 |
| 1055 | Epidermolysis bullosa simplex | Enrichment | ITGB4 | 0.79 |
| 1056 | Childhood-onset nemaline myopathy | Enrichment | ACTA1 | 0.79 |
| 1057 | Hypophosphatemic rickets | Enrichment | FGF23 | 0.79 |
| 1058 | B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) | Enrichment | TP53 | 0.79 |
| 1059 | Stargardt disease 1 | Enrichment | COL18A1, COL2A1 | 0.77 |
| 1060 | Malaria | Enrichment | FCGR2A, FCGR2B | 0.76 |
| 1061 | Congenital stationary night blindness | Enrichment | GNAT1, GNB3 | 0.76 |
| 1062 | West syndrome | Enrichment | GNAO1, NTRK2, PLCB1 | 0.76 |
| 1063 | Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy | Enrichment | CALM1 | 0.74 |
| 1064 | Spinocerebellar ataxia, autosomal recessive 16 | Enrichment | ITPR1 | 0.74 |
| 1065 | Hypertrichosis | Enrichment | CREBBP | 0.74 |
| 1066 | Arthrogryposis, distal, type 1a | Enrichment | MET | 0.74 |
| 1067 | Glioma susceptibility 1 | Enrichment | TP53 | 0.74 |
| 1068 | Isolated growth hormone deficiency, type ia | Enrichment | GH1 | 0.74 |
| 1069 | Mitochondrial dna depletion syndrome 4b | Enrichment | TYMP | 0.74 |
| 1070 | Congenital muscular dystrophy | Enrichment | LAMA2 | 0.74 |
| 1071 | Childhood-onset schizophrenia | Enrichment | FREM2 | 0.74 |
| 1072 | Orofacial cleft 1 | Enrichment | FGF10 | 0.69 |
| 1073 | Cardiomyopathy, familial hypertrophic, 4 | Enrichment | BRAF | 0.69 |
| 1074 | Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies | Enrichment | RAC1 | 0.69 |
| 1075 | Hypogonadotropic hypogonadism | Enrichment | FGFR1 | 0.69 |
| 1076 | Congenital central hypoventilation syndrome | Enrichment | BDNF | 0.69 |
| 1077 | Ventricular septal defect | Enrichment | BRAF | 0.69 |
| 1078 | Mitochondrial neurogastrointestinal encephalomyopathy | Enrichment | TYMP | 0.69 |
| 1079 | Myelofibrosis | Enrichment | SRC | 0.68 |
| 1080 | Brachydactyly | Enrichment | GNAS | 0.68 |
| 1081 | Common variable immunodeficiency | Enrichment | NFKB1 | 0.68 |
| 1082 | Cat eye syndrome | Enrichment | ACTG1 | 0.65 |
| 1083 | Leukemia, chronic lymphocytic | Enrichment | TP53 | 0.65 |
| 1084 | Meier-gorlin syndrome 1 | Enrichment | FGFR2 | 0.65 |
| 1085 | Nemaline myopathy | Enrichment | ACTA1 | 0.65 |
| 1086 | Familial colorectal cancer | Enrichment | TP53 | 0.65 |
| 1087 | Body mass index quantitative trait locus 11 | Enrichment | ADCY3, BDNF, GNAS | 0.65 |
| 1088 | Fetal akinesia deformation sequence 1 | Enrichment | ACTA1, FBN2 | 0.63 |
| 1089 | Fanconi anemia, complementation group c | Enrichment | HDAC8 | 0.63 |
| 1090 | Catecholaminergic polymorphic ventricular tachycardia 1 | Enrichment | CALM1 | 0.63 |
| 1091 | Hypothyroidism | Enrichment | GNB1 | 0.63 |
| 1092 | Choreatic disease | Enrichment | GNAO1 | 0.63 |
| 1093 | Myelodysplastic syndrome | Enrichment | TP53 | 0.62 |
| 1094 | Ichthyosis | Enrichment | COL7A1 | 0.62 |
| 1095 | Uterine corpus cancer | Enrichment | PTEN | 0.62 |
| 1096 | Heritable pulmonary arterial hypertension | Enrichment | GDF2 | 0.62 |
| 1097 | Nephrotic syndrome, type 1 | Enrichment | PLCE1 | 0.59 |
| 1098 | Charge syndrome | Enrichment | EP300 | 0.59 |
| 1099 | Developmental and epileptic encephalopathy 14 | Enrichment | PLCB1 | 0.59 |
| 1100 | Septooptic dysplasia | Enrichment | FGFR1 | 0.59 |
| 1101 | Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant | Enrichment | TGFB3 | 0.59 |
| 1102 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant | Enrichment | TGFB3 | 0.59 |
| 1103 | Postsynaptic congenital myasthenic syndromes | Enrichment | COL13A1 | 0.59 |
| 1104 | Congenital nervous system abnormality | Enrichment | CREBBP, FGFR3, GNAO1, GNB5, PLA2G6 | 0.57 |
| 1105 | Nervous system disease | Enrichment | CREBBP, FGFR3, GNAO1, GNB5, PLA2G6 | 0.57 |
| 1106 | Long qt syndrome | Enrichment | CALM1, CALM2 | 0.57 |
| 1107 | Aortic valve disease 1 | Enrichment | SOS1 | 0.56 |
| 1108 | Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly | Enrichment | COL5A1 | 0.56 |
| 1109 | Neural tube defects | Enrichment | ITGB1 | 0.56 |
| 1110 | Pulmonary hypertension, primary, 1 | Enrichment | GDF2 | 0.56 |
| 1111 | Clubfoot | Enrichment | COL5A1 | 0.56 |
| 1112 | Protein-deficiency anemia | Enrichment | NRAS | 0.56 |
| 1113 | Nk-cell enteropathy | Enrichment | IGF1R | 0.56 |
| 1114 | Undetermined early-onset epileptic encephalopathy | Enrichment | FGF12, NTRK2, PPP3CA | 0.56 |
| 1115 | Type 2 diabetes mellitus | Enrichment | AKT2, IL6 | 0.55 |
| 1116 | Distal arthrogryposis | Enrichment | ACTA1, COL25A1 | 0.55 |
| 1117 | Nonsyndromic hearing loss | Enrichment | ACTG1, COL11A2 | 0.55 |
| 1118 | Cystic fibrosis | Enrichment | FCGR2A, TGFB1 | 0.55 |
| 1119 | Ciliary dyskinesia, primary, 3 | Enrichment | NFKB1 | 0.55 |
| 1120 | Neurodegeneration with brain iron accumulation | Enrichment | PLA2G6 | 0.55 |
| 1121 | Achromatopsia | Enrichment | GNAT2 | 0.55 |
| 1122 | Hypogonadotropic hypogonadism 7 with or without anosmia | Enrichment | FGFR1 | 0.53 |
| 1123 | Walker-warburg syndrome | Enrichment | COL4A1 | 0.53 |
| 1124 | Generalized epilepsy with febrile seizures plus | Enrichment | FGF13 | 0.53 |
| 1125 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant | Enrichment | TGFB3 | 0.53 |
| 1126 | 46,xy partial gonadal dysgenesis | Enrichment | SOS1 | 0.53 |
| 1127 | Immune deficiency disease | Enrichment | SYK | 0.51 |
| 1128 | Leukemia, acute lymphoblastic | Enrichment | GNB1 | 0.51 |
| 1129 | Combined immunodeficiency | Enrichment | ZAP70 | 0.51 |
| 1130 | Atrial heart septal defect | Enrichment | HDAC8 | 0.51 |
| 1131 | Movement disease | Enrichment | GNAO1 | 0.51 |
| 1132 | Combined t cell and b cell immunodeficiency | Enrichment | ZAP70 | 0.51 |
| 1133 | Interatrial communication | Enrichment | HDAC8 | 0.51 |
| 1134 | Combined t and b cell immunodeficiency | Enrichment | ZAP70 | 0.51 |
| 1135 | Rare genetic deafness | Enrichment | ACTG1, COL11A2, COL4A5 | 0.51 |
| 1136 | Atypical hemolytic-uremic syndrome | Enrichment | COL4A5 | 0.50 |
| 1137 | Lynch syndrome | Enrichment | KRAS | 0.50 |
| 1138 | Dystonia | Enrichment | GNAL, GNB1 | 0.50 |
| 1139 | Eye disease | Enrichment | GNAT2, IMPG2 | 0.50 |
| 1140 | Congenital long qt syndrome | Enrichment | ITPR3 | 0.48 |
| 1141 | Creatine phosphokinase, elevated serum | Enrichment | LAMA2 | 0.48 |
| 1142 | Perrault syndrome 1 | Enrichment | FBN1 | 0.48 |
| 1143 | Isolated elevated serum creatine phosphokinase levels | Enrichment | LAMA2 | 0.48 |
| 1144 | Non-syndromic x-linked intellectual disability | Enrichment | ARHGEF6, RPS6KA3 | 0.48 |
| 1145 | Developmental and epileptic encephalopathy | Enrichment | ARHGEF15, GNAO1 | 0.48 |
| 1146 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | ADCY1, COL11A2, HGF, MET | 0.48 |
| 1147 | Melanoma, cutaneous malignant 1 | Enrichment | BRAF | 0.46 |
| 1148 | Human immunodeficiency virus type 1 | Enrichment | CXCL12 | 0.44 |
| 1149 | Neuromuscular disease | Enrichment | ACTA1 | 0.44 |
| 1150 | Patent foramen ovale | Enrichment | PSMC3 | 0.44 |
| 1151 | Cone-rod dystrophy 6 | Enrichment | GNAT2 | 0.43 |
| 1152 | Heart disease | Enrichment | CREBBP | 0.43 |
| 1153 | Congenital myopathy | Enrichment | ACTA1 | 0.42 |
| 1154 | Familial isolated dilated cardiomyopathy | Enrichment | LAMA4, RAF1 | 0.42 |
| 1155 | Polydactyly, postaxial, type a1 | Enrichment | EP300 | 0.40 |
| 1156 | Williams-beuren syndrome | Enrichment | ELN | 0.40 |
| 1157 | Macs syndrome | Enrichment | GDF6 | 0.40 |
| 1158 | Lissencephaly | Enrichment | ACTG1 | 0.39 |
| 1159 | Centronuclear myopathy | Enrichment | ACTA1 | 0.39 |
| 1160 | Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay | Enrichment | PLA2G6 | 0.38 |
| 1161 | Visceral heterotaxy | Enrichment | LEFTY2 | 0.37 |
| 1162 | Hypertension, essential | Enrichment | GNB3 | 0.36 |
| 1163 | Sudden infant death syndrome | Enrichment | CALM2 | 0.36 |
| 1164 | Diamond-blackfan anemia 1 | Enrichment | TP53 | 0.36 |
| 1165 | Charcot-marie-tooth disease type 4 | Enrichment | PLD3 | 0.35 |
| 1166 | Early infantile developmental and epileptic encephalopathy | Enrichment | GNAO1 | 0.35 |
| 1167 | Ear malformation | Enrichment | COL11A2 | 0.34 |
| 1168 | Cardiomyopathy, familial hypertrophic, 1 | Enrichment | RAF1 | 0.34 |
| 1169 | Muscular dystrophy | Enrichment | COL6A2 | 0.34 |
| 1170 | Brugada syndrome | Enrichment | SEMA3A | 0.32 |
| 1171 | Autism spectrum disorder | Enrichment | GNB1, MAP2K1, MEF2C, SMC3 | 0.32 |
| 1172 | Autosomal dominant non-syndromic intellectual disability | Enrichment | GNB1, PPP3CA | 0.31 |
| 1173 | Cardiomyopathy, dilated, 1a | Enrichment | NFATC2 | 0.30 |
| 1174 | Cone-rod dystrophy 2 | Enrichment | IMPG2, ITGA4 | 0.30 |
| 1175 | Hirschsprung disease 1 | Enrichment | NRG3 | 0.29 |
| 1176 | Severe covid-19 | Enrichment | ITGAV | 0.29 |
| 1177 | Attention deficit-hyperactivity disorder | Enrichment | GNB5 | 0.28 |
| 1178 | Spastic ataxia | Enrichment | ITPR1, PLA2G6 | 0.28 |
| 1179 | Cone dystrophy | Enrichment | GNAT2 | 0.26 |
| 1180 | Peripheral nervous system disease | Enrichment | NGF | 0.26 |
| 1181 | Neuropathy | Enrichment | NGF | 0.26 |
| 1182 | Familial hypertrophic cardiomyopathy | Enrichment | RAF1 | 0.25 |
| 1183 | Developmental and epileptic encephalopathy 1 | Enrichment | GNAO1 | 0.25 |
| 1184 | Left ventricular noncompaction | Enrichment | RAF1 | 0.23 |
| 1185 | Strabismus | Enrichment | GNB1 | 0.23 |
| 1186 | Diamond-blackfan anemia | Enrichment | TP53 | 0.23 |
| 1187 | Non-syndromic genetic deafness | Enrichment | ACTG1 | 0.23 |
| 1188 | Autism | Enrichment | COL11A1, CREBBP | 0.16 |
| 1189 | Benign epilepsy with centrotemporal spikes | Enrichment | PLCB1 | 0.13 |
| 1190 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | Enrichment | FGF8 | 0.12 |
| 1191 | Centralopathic epilepsy | Enrichment | PLCB1 | 0.12 |
| 1192 | Complex neurodevelopmental disorder | Enrichment | GNB2, RAC3, RALA | 0.11 |
| 1193 | Primary ciliary dyskinesia | Enrichment | DRC4 | 0.07 |
| 1194 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | MEF2C | 0.07 |
| 1195 | Mitochondrial disease | Enrichment | GFER | 0.05 |
| 1196 | Retinitis pigmentosa | Enrichment | COL18A1, IMPG1, IMPG2 | 0.05 |
| 1197 | Leber plus disease | Enrichment | GDF6 | 0.04 |